FUJIFILM Diosynth Biotechnologies UK Limited

Royaume‑Uni

Retour au propriétaire

1-81 de 81 pour FUJIFILM Diosynth Biotechnologies UK Limited Trier par
Recheche Texte
Affiner par
Type PI
        Brevet 58
        Marque 23
Juridiction
        États-Unis 37
        International 34
        Canada 9
        Europe 1
Date
Nouveautés (dernières 4 semaines) 2
2025 février 2
2025 janvier 1
2024 décembre 5
2025 (AACJ) 3
Voir plus
Classe IPC
C12N 15/70 - Vecteurs ou systèmes d'expression spécialement adaptés à E. coli 14
C12N 15/10 - Procédés pour l'isolement, la préparation ou la purification d'ADN ou d'ARN 12
C07K 1/34 - ExtractionSéparationPurification par filtration, ultrafiltration ou osmose inverse 10
G01N 30/34 - Contrôle des paramètres physiques du fluide vecteur de la composition du fluide, p. ex. du gradient 9
C12N 15/85 - Vecteurs ou systèmes d'expression spécialement adaptés aux hôtes eucaryotes pour cellules animales 8
Voir plus
Classe NICE
40 - Traitement de matériaux; recyclage, purification de l'air et traitement de l'eau 23
42 - Services scientifiques, technologiques et industriels, recherche et conception 23
01 - Produits chimiques destinés à l'industrie, aux sciences ainsi qu'à l'agriculture 11
37 - Services de construction; extraction minière; installation et réparation 8
09 - Appareils et instruments scientifiques et électriques 2
Voir plus
Statut
En Instance 18
Enregistré / En vigueur 63

1.

SEQUENCES AND METHODS FOR PRODUCTION OF RECOMBINANT BIOLOGICAL MOLECULES IN VESICLES

      
Numéro d'application 18719423
Statut En instance
Date de dépôt 2022-12-15
Date de la première publication 2025-02-20
Propriétaire
  • University of Kent (Royaume‑Uni)
  • Fujifilm Diosynth Biotechnologies UK Limited (Royaume‑Uni)
Inventeur(s)
  • Mulvihill, Daniel
  • Baker, Karen
  • Eastwood, Tara
  • Lennon, Christopher

Abrégé

Described is a method and component parts of a recombinant expression system for the expression of a biological molecule. In particular, an isolated vesicle nucleating polypeptide (VNp) comprising an amphipathic alpha helix polypeptide derived from the amino terminus of synuclein isoforms and variants thereof is used to promote, enhance or increase the formation of vesicles in the expression system to enable purification of the biological molecule.

Classes IPC  ?

  • C12P 21/00 - Préparation de peptides ou de protéines
  • C07K 14/47 - Peptides ayant plus de 20 amino-acidesGastrinesSomatostatinesMélanotropinesLeurs dérivés provenant d'animauxPeptides ayant plus de 20 amino-acidesGastrinesSomatostatinesMélanotropinesLeurs dérivés provenant d'humains provenant de vertébrés provenant de mammifères
  • C12N 15/62 - Séquences d'ADN codant pour des protéines de fusion
  • C12N 15/70 - Vecteurs ou systèmes d'expression spécialement adaptés à E. coli

2.

Partners for the Planet

      
Numéro d'application 1838867
Statut Enregistrée
Date de dépôt 2024-08-28
Date d'enregistrement 2024-08-28
Propriétaire FUJIFILM Diosynth Biotechnologies UK Limited (Royaume‑Uni)
Classes de Nice  ?
  • 37 - Services de construction; extraction minière; installation et réparation
  • 40 - Traitement de matériaux; recyclage, purification de l'air et traitement de l'eau
  • 42 - Services scientifiques, technologiques et industriels, recherche et conception

Produits et services

Construction services; building services; construction of pharmaceutical facilities; onsite management relating to the construction of pharmaceutical manufacturing facilities; building and construction of factories; custom construction of factories and pharmaceutical manufacturing facilities; information, advice and consultancy in relation to all the aforesaid. Custom processing and manufacturing services; custom processing and manufacturing of pharmaceuticals; custom manufacture of pharmaceuticals; manufacture, processing and production of recombinant proteins for use in the biotechnology industries to the order and specification of others; cell culture manufacturing services for others; custom manufacture of biologics; information, advice and consultancy in relation to all the aforesaid. Scientific and technological services; research and development; scientific, industrial and technical research, development and analysis services; scientific, industrial and technical research, development and analysis services in the field of biotechnology; process development (term considered too vague by the International Bureau pursuant to Rule 13 (2) (b) of the Regulations); development of processes for the use in the manufacture of biotechnology products; project studies (term considered too vague by the International Bureau pursuant to Rule 13 (2) (b) of the Regulations); biotechnology testing; research and consultancy in the field of biotechnology; research and development in the pharmaceutical and biotechnology industry; scientific, technological and pharmaceutical process development and design; biopharmaceutical product development; software development, programming and implementation; design and development of software; design and development of manufacturing processes in the field of biopharmaceuticals; design of manufacturing methods; design of industrial buildings; design of manufacturing plants; engineering services; research laboratories; preparations of biological samples for analysis in research laboratories (term considered linguistically incorrect by the International Bureau pursuant to Rule 13 (2) (b) of the Regulations); designs services relating to process systems for the biotechnology industry; design services relating to plant for the biotechnology industry; information, advice and consultancy in relation to all the aforesaid.

3.

KojoX

      
Numéro d'application 1832902
Statut Enregistrée
Date de dépôt 2024-08-28
Date d'enregistrement 2024-08-28
Propriétaire FUJIFILM Diosynth Biotechnologies UK Limited (Royaume‑Uni)
Classes de Nice  ?
  • 37 - Services de construction; extraction minière; installation et réparation
  • 40 - Traitement de matériaux; recyclage, purification de l'air et traitement de l'eau
  • 42 - Services scientifiques, technologiques et industriels, recherche et conception

Produits et services

Construction services; building services; construction of pharmaceutical facilities; onsite management relating to the construction of pharmaceutical manufacturing facilities; building and construction of factories; custom construction of factories and pharmaceutical manufacturing facilities; information, advice and consultancy in relation to all the aforesaid. Custom processing and manufacturing services; custom processing and manufacturing of pharmaceuticals; custom manufacture of pharmaceuticals; manufacture, processing and production of recombinant proteins for use in the biotechnology industries to the order and specification of others; cell culture manufacturing services for others; custom manufacture of biologics; information, advice and consultancy in relation to all the aforesaid. Scientific and technological services; research and development; scientific, industrial and technical research, development and analysis services; scientific, industrial and technical research, development and analysis services in the field of biotechnology; industrial process development; development of processes for the use in the manufacture of biotechnology products; technical project studies; biotechnology testing; research and consultancy in the field of biotechnology; research and development in the pharmaceutical and biotechnology industry; scientific, technological and pharmaceutical process development and design; biopharmaceutical product development; software development, programming and implementation; design and development of software; design and development of manufacturing processes in the field of biopharmaceuticals; design of manufacturing methods; design of industrial buildings; design of manufacturing plants; engineering services; research laboratories; preparations of biological samples for analysis in research laboratories; designs services relating to process systems for the biotechnology industry; design services relating to plant for the biotechnology industry; information, advice and consultancy in relation to all the aforesaid.

4.

ApolloX

      
Numéro d'application 1828298
Statut Enregistrée
Date de dépôt 2024-08-28
Date d'enregistrement 2024-08-28
Propriétaire Fujifilm Diosynth Biotechnologies UK Limited (Royaume‑Uni)
Classes de Nice  ?
  • 01 - Produits chimiques destinés à l'industrie, aux sciences ainsi qu'à l'agriculture
  • 40 - Traitement de matériaux; recyclage, purification de l'air et traitement de l'eau
  • 42 - Services scientifiques, technologiques et industriels, recherche et conception

Produits et services

Cell cultures used in industry and science; mammalian cell cultures and vectors, being independent replicating pieces of DNA that can transfer DNA sequences, each for manufacture and development in the biotechnology industries; biological preparations for use in science; biological preparations for use in cell cultures; cell culture reagents for scientific and research use; media for cell culture for use in the biotechnological industry; chemical products for biotechnological purposes; chemicals for use in biotechnological manufacturing processes. Processing and manufacturing of vectors, cell cultures and recombinant proteins for use in biotechnology industries to the order and specification of others; manufacture, processing and production of recombinant proteins for use in the biotechnology industries to the order and specification of others; custom processing and manufacturing services in the field of biopharmaceuticals; custom processing and manufacturing of biological products; custom manufacture of biopharmaceuticals; cell culture manufacturing services for others; custom manufacture of biologics; information, advice and consultancy in relation to all the aforesaid. Scientific, industrial and technical research, development and analysis services; development and analysis services relating to the use of mammalian cell cultures and vectors in the field of biotechnology; biotechnology process development; development of processes for the use of mammalian cell cultures and vectors in the manufacture of biotechnology products; technical project studies; project studies relating to the use of mammalian cell cultures and vectors in the field of biotechnology; development of processes for the use in the manufacture of biotechnology products; technical project studies; biotechnology testing; research and consultancy in the field of biotechnology; research and development in the pharmaceutical and biotechnology industry; scientific, technological and pharmaceutical process development and design; biopharmaceutical product development; design and development of manufacturing processes in the field of biopharmaceuticals; development of chemicals for use in the manufacture of biotechnology products and pharmaceuticals; preparation of biological samples for analysis in research laboratories; information, advice and consultancy in relation to all the aforesaid.

5.

kojoX

      
Numéro d'application 1828282
Statut Enregistrée
Date de dépôt 2024-08-28
Date d'enregistrement 2024-08-28
Propriétaire FUJIFILM Diosynth Biotechnologies UK Limited (Royaume‑Uni)
Classes de Nice  ?
  • 37 - Services de construction; extraction minière; installation et réparation
  • 40 - Traitement de matériaux; recyclage, purification de l'air et traitement de l'eau
  • 42 - Services scientifiques, technologiques et industriels, recherche et conception

Produits et services

Construction services; building services; construction of pharmaceutical facilities; onsite management relating to the construction of pharmaceutical manufacturing facilities; building and construction of factories; custom construction of factories and pharmaceutical manufacturing facilities; information, advice and consultancy in relation to all the aforesaid. Custom processing and manufacturing services; custom processing and manufacturing of pharmaceuticals; custom manufacture of pharmaceuticals; manufacture, processing and production of recombinant proteins for use in the biotechnology industries to the order and specification of others; cell culture manufacturing services for others; custom manufacture of biologics; information, advice and consultancy in relation to all the aforesaid. Scientific and technological services; research and development; scientific, industrial and technical research, development and analysis services; scientific, industrial and technical research, development and analysis services in the field of biotechnology; industrial process development; development of processes for the use in the manufacture of biotechnology products; technical project studies; biotechnology testing; research and consultancy in the field of biotechnology; research and development in the pharmaceutical and biotechnology industry; scientific, technological and pharmaceutical process development and design; biopharmaceutical product development; software development, programming and implementation; design and development of software; design and development of manufacturing processes in the field of biopharmaceuticals; design of manufacturing methods; design of industrial buildings; design of manufacturing plants; engineering services; research laboratories; preparation of biological samples for analysis in research laboratories; designs services relating to process systems for the biotechnology industry; design services relating to plant for the biotechnology industry; information, advice and consultancy in relation to all the aforesaid.

6.

PAVEWAY

      
Numéro d'application 1827765
Statut Enregistrée
Date de dépôt 2024-08-28
Date d'enregistrement 2024-08-28
Propriétaire FUJIFILM Diosynth Biotechnologies UK Limited (Royaume‑Uni)
Classes de Nice  ?
  • 01 - Produits chimiques destinés à l'industrie, aux sciences ainsi qu'à l'agriculture
  • 40 - Traitement de matériaux; recyclage, purification de l'air et traitement de l'eau
  • 42 - Services scientifiques, technologiques et industriels, recherche et conception

Produits et services

Chemicals used in industry and science; cell cultures used in industry and science; biological preparations for use in science; biological preparations for use in cell cultures; proteins for use in industry, enzymes; microbial preparations being chemicals for industry; cultures of micro-organisms other than for medical or veterinary use; chemical reagents; organic chemicals for use in science, namely genes being DNA sequences; plasmids being small independently replicating pieces of DNA and vectors being small independently replicating pieces of DNA that can transfer DNA sequences, being chemicals for use in science; cell culture reagents for scientific and research use; media for cell culture for use in the biotechnological industry; chemical products for biotechnological purposes; chemicals for use in biotechnological manufacturing processes. Processing and manufacturing of chemicals and proteins; custom manufacture of chemicals and proteins for use in biotechnology and pharmaceuticals; manufacture, processing and production of scientific and industrial products to the order and specification of others; custom processing and manufacturing services; custom processing and manufacturing of biological products; custom manufacture of biopharmaceuticals; manufacture, processing and production of recombinant proteins for use in the biotechnology industries to the order and specification of others; cell culture manufacturing services for others; custom manufacture of biologics; information, advice and consultancy in relation to all the aforesaid. Scientific, industrial and technical research; scientific analysis; technological analysis services; scientific research and development; industrial process development; industrial design services; provision of facilities for scientific, industrial and technical research and development; research and development of scientific, industrial and technical products; technical project studies; testing of scientific, industrial and technical products; scientific, industrial and technical research, development and analysis services in the field of biotechnology; development of processes for the use in the manufacture of biotechnology products; project studies; biotechnology testing; research and consultancy in the field of biotechnology; research and development in the pharmaceutical and biotechnology industry; scientific, technological and pharmaceutical process development and design; biopharmaceutical product development; design and development of manufacturing processes in the field of biopharmaceuticals; development of chemicals for use in the manufacture of biotechnology products and pharmaceuticals; preparation of biological samples for analysis in research laboratories; information, advice and consultancy in relation to all the aforesaid.

7.

ApolloX

      
Numéro d'application 1826250
Statut Enregistrée
Date de dépôt 2024-08-28
Date d'enregistrement 2024-08-28
Propriétaire Fujifilm Diosynth Biotechnologies UK Limited (Royaume‑Uni)
Classes de Nice  ?
  • 01 - Produits chimiques destinés à l'industrie, aux sciences ainsi qu'à l'agriculture
  • 40 - Traitement de matériaux; recyclage, purification de l'air et traitement de l'eau
  • 42 - Services scientifiques, technologiques et industriels, recherche et conception

Produits et services

Cell cultures used in industry and science; mammalian cell cultures and vectors, being independent replicating pieces of DNA that can transfer DNA sequences, each for manufacture and development in the biotechnology industries; biological preparations for use in science; biological preparations for use in cell cultures; cell culture reagents for scientific and research use; media for cell culture for use in the biotechnological industry; chemical products for biotechnological purposes; chemicals for use in biotechnological manufacturing processes. Processing and manufacturing of vectors, cell cultures and recombinant proteins for use in biotechnology industries to the order and specification of others; manufacture, processing and production of recombinant proteins for use in the biotechnology industries to the order and specification of others; custom processing and manufacturing services; custom processing and manufacturing of biological products; custom manufacture of biopharmaceuticals; cell culture manufacturing services for others; custom manufacture of biologics; information, advice and consultancy in relation to all the aforesaid. Scientific, industrial and technical research, development and analysis services; development and analysis services relating to the use of mammalian cell cultures and vectors in the field of biotechnology; industrial process development; development of processes for the use of mammalian cell cultures and vectors in the manufacture of biotechnology products; technical project studies; project studies relating to the use of mammalian cell cultures and vectors in the field of biotechnology; development of processes for the use in the manufacture of biotechnology products; technical project studies; biotechnology testing; research and consultancy in the field of biotechnology; research and development in the pharmaceutical and biotechnology industry; scientific, technological and pharmaceutical process development and design; biopharmaceutical product development; design and development of manufacturing processes in the field of biopharmaceuticals; development of chemicals for use in the manufacture of biotechnology products and pharmaceuticals; preparation of biological samples for analysis in research laboratories; information, advice and consultancy in relation to all the aforesaid.

8.

Partners for the Planet

      
Numéro d'application 1826249
Statut Enregistrée
Date de dépôt 2024-08-28
Date d'enregistrement 2024-08-28
Propriétaire FUJIFILM Diosynth Biotechnologies UK Limited (Royaume‑Uni)
Classes de Nice  ?
  • 37 - Services de construction; extraction minière; installation et réparation
  • 40 - Traitement de matériaux; recyclage, purification de l'air et traitement de l'eau
  • 42 - Services scientifiques, technologiques et industriels, recherche et conception

Produits et services

Construction services; building services; construction of pharmaceutical facilities; onsite management relating to the construction of pharmaceutical manufacturing facilities; building and construction of factories; custom construction of factories and pharmaceutical manufacturing facilities; information, advice and consultancy in relation to all the aforesaid. Custom processing and manufacturing services; custom processing and manufacturing of pharmaceuticals; custom manufacture of pharmaceuticals; manufacture, processing and production of recombinant proteins for use in the biotechnology industries to the order and specification of others; cell culture manufacturing services for others; custom manufacture of biologics; information, advice and consultancy in relation to all the aforesaid. Scientific and technological services; research and development; scientific, industrial and technical research, development and analysis services; scientific, industrial and technical research, development and analysis services in the field of biotechnology; industrial process development; development of processes for the use in the manufacture of biotechnology products; technical project studies; biotechnology testing; research and consultancy in the field of biotechnology; research and development in the pharmaceutical and biotechnology industry; scientific, technological and pharmaceutical process development and design; biopharmaceutical product development; software development, programming and implementation; design and development of software; design and development of manufacturing processes in the field of biopharmaceuticals; design of manufacturing methods; design of industrial buildings; design of manufacturing plants; engineering services; research laboratories; preparation of biological samples for analysis in research laboratories; designs services relating to process systems for the biotechnology industry; design services relating to plant for the biotechnology industry; information, advice and consultancy in relation to all the aforesaid.

9.

APOLLOX

      
Numéro de série 79411378
Statut En instance
Date de dépôt 2024-08-28
Propriétaire Fujifilm Diosynth Biotechnologies UK Limited (Royaume‑Uni)
Classes de Nice  ?
  • 01 - Produits chimiques destinés à l'industrie, aux sciences ainsi qu'à l'agriculture
  • 40 - Traitement de matériaux; recyclage, purification de l'air et traitement de l'eau
  • 42 - Services scientifiques, technologiques et industriels, recherche et conception

Produits et services

Cell cultures used in industry and science; mammalian cell cultures and vectors, being independent replicating pieces of DNA that can transfer DNA sequences, each for manufacture and development in the biotechnology industries; biological preparations for use in science; biological preparations for use in cell cultures; cell culture reagents for scientific and research use; media for cell culture for use in the biotechnological industry; chemical products for biotechnological purposes; chemicals for use in biotechnological manufacturing processes. Processing and manufacturing of vectors, cell cultures and recombinant proteins for use in biotechnology industries to the order and specification of others; manufacture, processing and production of recombinant proteins for use in the biotechnology industries to the order and specification of others; custom processing and manufacturing services; custom processing and manufacturing of biological products; custom manufacture of biopharmaceuticals; cell culture manufacturing services for others; custom manufacture of biologics; information, advice and consultancy in relation to all the aforesaid. Scientific, industrial and technical research, development and analysis services; development and analysis services relating to the use of mammalian cell cultures and vectors in the field of biotechnology; industrial process development; development of processes for the use of mammalian cell cultures and vectors in the manufacture of biotechnology products; technical project studies; project studies relating to the use of mammalian cell cultures and vectors in the field of biotechnology; development of processes for the use in the manufacture of biotechnology products; technical project studies; biotechnology testing; research and consultancy in the field of biotechnology; research and development in the pharmaceutical and biotechnology industry; scientific, technological and pharmaceutical process development and design; biopharmaceutical product development; design and development of manufacturing processes in the field of biopharmaceuticals; development of chemicals for use in the manufacture of biotechnology products and pharmaceuticals; preparation of biological samples for analysis in research laboratories; information, advice and consultancy in relation to all the aforesaid.

10.

PAVEWAY

      
Numéro de série 79412046
Statut En instance
Date de dépôt 2024-08-28
Propriétaire FUJIFILM Diosynth Biotechnologies UK Limited (Royaume‑Uni)
Classes de Nice  ?
  • 01 - Produits chimiques destinés à l'industrie, aux sciences ainsi qu'à l'agriculture
  • 40 - Traitement de matériaux; recyclage, purification de l'air et traitement de l'eau
  • 42 - Services scientifiques, technologiques et industriels, recherche et conception

Produits et services

Chemicals used in industry and science; cell cultures used in industry and science; biological preparations for use in science; biological preparations for use in cell cultures; proteins for use in industry, enzymes; microbial preparations being chemicals for industry; cultures of micro-organisms other than for medical or veterinary use; chemical reagents; organic chemicals for use in science, namely genes being DNA sequences; plasmids being small independently replicating pieces of DNA and vectors being small independently replicating pieces of DNA that can transfer DNA sequences, being chemicals for use in science; cell culture reagents for scientific and research use; media for cell culture for use in the biotechnological industry; chemical products for biotechnological purposes; chemicals for use in biotechnological manufacturing processes. Processing and manufacturing of chemicals and proteins; custom manufacture of chemicals and proteins for use in biotechnology and pharmaceuticals; manufacture, processing and production of scientific and industrial products to the order and specification of others; custom processing and manufacturing services; custom processing and manufacturing of biological products; custom manufacture of biopharmaceuticals; manufacture, processing and production of recombinant proteins for use in the biotechnology industries to the order and specification of others; cell culture manufacturing services for others; custom manufacture of biologics; information, advice and consultancy in relation to all the aforesaid. Scientific, industrial and technical research; scientific analysis; technological analysis services; scientific research and development; industrial process development; industrial design services; provision of facilities for scientific, industrial and technical research and development; research and development of scientific, industrial and technical products; technical project studies; testing of scientific, industrial and technical products; scientific, industrial and technical research, development and analysis services in the field of biotechnology; development of processes for the use in the manufacture of biotechnology products; project studies; biotechnology testing; research and consultancy in the field of biotechnology; research and development in the pharmaceutical and biotechnology industry; scientific, technological and pharmaceutical process development and design; biopharmaceutical product development; design and development of manufacturing processes in the field of biopharmaceuticals; development of chemicals for use in the manufacture of biotechnology products and pharmaceuticals; preparation of biological samples for analysis in research laboratories; information, advice and consultancy in relation to all the aforesaid.

11.

KOJOX

      
Numéro de série 79412324
Statut En instance
Date de dépôt 2024-08-28
Propriétaire FUJIFILM Diosynth Biotechnologies UK Limited (Royaume‑Uni)
Classes de Nice  ?
  • 40 - Traitement de matériaux; recyclage, purification de l'air et traitement de l'eau
  • 37 - Services de construction; extraction minière; installation et réparation
  • 42 - Services scientifiques, technologiques et industriels, recherche et conception

Produits et services

Custom processing and manufacturing services; custom processing and manufacturing of pharmaceuticals; custom manufacture of pharmaceuticals; manufacture, processing and production of recombinant proteins for use in the biotechnology industries to the order and specification of others; cell culture manufacturing services for others; custom manufacture of biologics; information, advice and consultancy in relation to all the aforesaid. Construction services; building services; construction of pharmaceutical facilities; onsite management relating to the construction of pharmaceutical manufacturing facilities; building and construction of factories; custom construction of factories and pharmaceutical manufacturing facilities; information, advice and consultancy in relation to all the aforesaid. Scientific and technological services; research and development; scientific, industrial and technical research, development and analysis services; scientific, industrial and technical research, development and analysis services in the field of biotechnology; industrial process development; development of processes for the use in the manufacture of biotechnology products; technical project studies; biotechnology testing; research and consultancy in the field of biotechnology; research and development in the pharmaceutical and biotechnology industry; scientific, technological and pharmaceutical process development and design; biopharmaceutical product development; software development, programming and implementation; design and development of software; design and development of manufacturing processes in the field of biopharmaceuticals; design of manufacturing methods; design of industrial buildings; design of manufacturing plants; engineering services; research laboratories; preparation of biological samples for analysis in research laboratories; designs services relating to process systems for the biotechnology industry; design services relating to plant for the biotechnology industry; information, advice and consultancy in relation to all the aforesaid.

12.

APOLLOX

      
Numéro de série 79412331
Statut En instance
Date de dépôt 2024-08-28
Propriétaire Fujifilm Diosynth Biotechnologies UK Limited (Royaume‑Uni)
Classes de Nice  ?
  • 01 - Produits chimiques destinés à l'industrie, aux sciences ainsi qu'à l'agriculture
  • 40 - Traitement de matériaux; recyclage, purification de l'air et traitement de l'eau
  • 42 - Services scientifiques, technologiques et industriels, recherche et conception

Produits et services

Cell cultures used in industry and science; mammalian cell cultures and vectors, being independent replicating pieces of DNA that can transfer DNA sequences, each for manufacture and development in the biotechnology industries; biological preparations for use in science; biological preparations for use in cell cultures; cell culture reagents for scientific and research use; media for cell culture for use in the biotechnological industry; chemical products for biotechnological purposes; chemicals for use in biotechnological manufacturing processes. Processing and manufacturing of vectors, cell cultures and recombinant proteins for use in biotechnology industries to the order and specification of others; manufacture, processing and production of recombinant proteins for use in the biotechnology industries to the order and specification of others; custom processing and manufacturing services in the field of biopharmaceuticals; custom processing and manufacturing of biological products; custom manufacture of biopharmaceuticals; cell culture manufacturing services for others; custom manufacture of biologics; information, advice and consultancy in relation to all the aforesaid. Scientific, industrial and technical research, development and analysis services; development and analysis services relating to the use of mammalian cell cultures and vectors in the field of biotechnology; biotechnology process development; development of processes for the use of mammalian cell cultures and vectors in the manufacture of biotechnology products; technical project studies; project studies relating to the use of mammalian cell cultures and vectors in the field of biotechnology; development of processes for the use in the manufacture of biotechnology products; technical project studies; biotechnology testing; research and consultancy in the field of biotechnology; research and development in the pharmaceutical and biotechnology industry; scientific, technological and pharmaceutical process development and design; biopharmaceutical product development; design and development of manufacturing processes in the field of biopharmaceuticals; development of chemicals for use in the manufacture of biotechnology products and pharmaceuticals; preparation of biological samples for analysis in research laboratories; information, advice and consultancy in relation to all the aforesaid.

13.

PARTNERS FOR THE PLANET

      
Numéro de série 79416924
Statut En instance
Date de dépôt 2024-08-28
Propriétaire FUJIFILM Diosynth Biotechnologies UK Limited (Royaume‑Uni)
Classes de Nice  ?
  • 40 - Traitement de matériaux; recyclage, purification de l'air et traitement de l'eau
  • 37 - Services de construction; extraction minière; installation et réparation
  • 42 - Services scientifiques, technologiques et industriels, recherche et conception

Produits et services

Custom processing and manufacturing services; custom processing and manufacturing of pharmaceuticals; custom manufacture of pharmaceuticals; manufacture, processing and production of recombinant proteins for use in the biotechnology industries to the order and specification of others; cell culture manufacturing services for others; custom manufacture of biologics; information, advice and consultancy in relation to all the aforesaid. Construction services; building services; construction of pharmaceutical facilities; onsite management relating to the construction of pharmaceutical manufacturing facilities; building and construction of factories; custom construction of factories and pharmaceutical manufacturing facilities; information, advice and consultancy in relation to all the aforesaid. Scientific and technological services; research and development; scientific, industrial and technical research, development and analysis services; scientific, industrial and technical research, development and analysis services in the field of biotechnology; process development (term considered too vague by the International Bureau pursuant to Rule 13 (2) (b) of the Regulations); development of processes for the use in the manufacture of biotechnology products; project studies (term considered too vague by the International Bureau pursuant to Rule 13 (2) (b) of the Regulations); biotechnology testing; research and consultancy in the field of biotechnology; research and development in the pharmaceutical and biotechnology industry; scientific, technological and pharmaceutical process development and design; biopharmaceutical product development; software development, programming and implementation; design and development of software; design and development of manufacturing processes in the field of biopharmaceuticals; design of manufacturing methods; design of industrial buildings; design of manufacturing plants; engineering services; research laboratories; preparations of biological samples for analysis in research laboratories (term considered linguistically incorrect by the International Bureau pursuant to Rule 13 (2) (b) of the Regulations); designs services relating to process systems for the biotechnology industry; design services relating to plant for the biotechnology industry; information, advice and consultancy in relation to all the aforesaid.

14.

PARTNERS FOR THE PLANET

      
Numéro de série 79411452
Statut En instance
Date de dépôt 2024-08-28
Propriétaire FUJIFILM Diosynth Biotechnologies UK Limited (Royaume‑Uni)
Classes de Nice  ?
  • 40 - Traitement de matériaux; recyclage, purification de l'air et traitement de l'eau
  • 37 - Services de construction; extraction minière; installation et réparation
  • 42 - Services scientifiques, technologiques et industriels, recherche et conception

Produits et services

Custom processing and manufacturing services; custom processing and manufacturing of pharmaceuticals; custom manufacture of pharmaceuticals; manufacture, processing and production of recombinant proteins for use in the biotechnology industries to the order and specification of others; cell culture manufacturing services for others; custom manufacture of biologics; information, advice and consultancy in relation to all the aforesaid. Construction services; building services; construction of pharmaceutical facilities; onsite management relating to the construction of pharmaceutical manufacturing facilities; building and construction of factories; custom construction of factories and pharmaceutical manufacturing facilities; information, advice and consultancy in relation to all the aforesaid. Scientific and technological services; research and development; scientific, industrial and technical research, development and analysis services; scientific, industrial and technical research, development and analysis services in the field of biotechnology; industrial process development; development of processes for the use in the manufacture of biotechnology products; technical project studies; biotechnology testing; research and consultancy in the field of biotechnology; research and development in the pharmaceutical and biotechnology industry; scientific, technological and pharmaceutical process development and design; biopharmaceutical product development; software development, programming and implementation; design and development of software; design and development of manufacturing processes in the field of biopharmaceuticals; design of manufacturing methods; design of industrial buildings; design of manufacturing plants; engineering services; research laboratories; preparation of biological samples for analysis in research laboratories; designs services relating to process systems for the biotechnology industry; design services relating to plant for the biotechnology industry; information, advice and consultancy in relation to all the aforesaid.

15.

KOJOX

      
Numéro de série 79414333
Statut En instance
Date de dépôt 2024-08-28
Propriétaire FUJIFILM Diosynth Biotechnologies UK Limited (Royaume‑Uni)
Classes de Nice  ?
  • 40 - Traitement de matériaux; recyclage, purification de l'air et traitement de l'eau
  • 37 - Services de construction; extraction minière; installation et réparation
  • 42 - Services scientifiques, technologiques et industriels, recherche et conception

Produits et services

Custom processing and manufacturing services; custom processing and manufacturing of pharmaceuticals; custom manufacture of pharmaceuticals; manufacture, processing and production of recombinant proteins for use in the biotechnology industries to the order and specification of others; cell culture manufacturing services for others; custom manufacture of biologics; information, advice and consultancy in relation to all the aforesaid. Construction services; building services; construction of pharmaceutical facilities; onsite management relating to the construction of pharmaceutical manufacturing facilities; building and construction of factories; custom construction of factories and pharmaceutical manufacturing facilities; information, advice and consultancy in relation to all the aforesaid. Scientific and technological services; research and development; scientific, industrial and technical research, development and analysis services; scientific, industrial and technical research, development and analysis services in the field of biotechnology; industrial process development; development of processes for the use in the manufacture of biotechnology products; technical project studies; biotechnology testing; research and consultancy in the field of biotechnology; research and development in the pharmaceutical and biotechnology industry; scientific, technological and pharmaceutical process development and design; biopharmaceutical product development; software development, programming and implementation; design and development of software; design and development of manufacturing processes in the field of biopharmaceuticals; design of manufacturing methods; design of industrial buildings; design of manufacturing plants; engineering services; research laboratories; preparations of biological samples for analysis in research laboratories; designs services relating to process systems for the biotechnology industry; design services relating to plant for the biotechnology industry; information, advice and consultancy in relation to all the aforesaid.

16.

SEQUENCES AND METHODS FOR PRODUCTION OF RECOMBINANT BIOLOGICAL MOLECULES IN VESICLES

      
Numéro d'application GB2022053239
Numéro de publication 2023/111569
Statut Délivré - en vigueur
Date de dépôt 2022-12-15
Date de publication 2023-06-22
Propriétaire
  • UNIVERSITY OF KENT (Royaume‑Uni)
  • FUJIFILM DIOSYNTH BIOTECHNOLOGIES UK LIMITED (Royaume‑Uni)
Inventeur(s)
  • Mulvihill, Daniel
  • Baker, Karen
  • Eastwood, Tara
  • Lennon, Christopher

Abrégé

Described is a method and component parts of a recombinant expression system for the expression of a biological molecule. In particular, an isolated vesicle nucleating polypeptide (VNp) comprising an amphipathic alpha helix polypeptide derived from the amino terminus of synuclein isoforms and variants thereof is used to promote, enhance or increase the formation of vesicles in the expression system to enable purification of the biological molecule.

Classes IPC  ?

  • C07K 14/47 - Peptides ayant plus de 20 amino-acidesGastrinesSomatostatinesMélanotropinesLeurs dérivés provenant d'animauxPeptides ayant plus de 20 amino-acidesGastrinesSomatostatinesMélanotropinesLeurs dérivés provenant d'humains provenant de vertébrés provenant de mammifères
  • A61K 9/50 - Microcapsules
  • C12N 9/50 - Protéinases
  • C12N 15/67 - Méthodes générales pour favoriser l'expression
  • C12P 21/02 - Préparation de peptides ou de protéines comportant une séquence connue de plusieurs amino-acides, p. ex. glutathion

17.

SEQUENCES AND METHODS FOR PRODUCTION OF RECOMBINANT BIOLOGICAL MOLECULES IN VESICLES

      
Numéro de document 03238296
Statut En instance
Date de dépôt 2022-12-15
Date de disponibilité au public 2023-06-22
Propriétaire
  • UNIVERSITY OF KENT (Royaume‑Uni)
  • FUJIFILM DIOSYNTH BIOTECHNOLOGIES UK LIMITED (Royaume‑Uni)
Inventeur(s)
  • Mulvihill, Daniel
  • Baker, Karen
  • Eastwood, Tara
  • Lennon, Christopher

Abrégé

Described is a method and component parts of a recombinant expression system for the expression of a biological molecule. In particular, an isolated vesicle nucleating polypeptide (VNp) comprising an amphipathic alpha helix polypeptide derived from the amino terminus of synuclein isoforms and variants thereof is used to promote, enhance or increase the formation of vesicles in the expression system to enable purification of the biological molecule.

Classes IPC  ?

  • C07K 14/47 - Peptides ayant plus de 20 amino-acidesGastrinesSomatostatinesMélanotropinesLeurs dérivés provenant d'animauxPeptides ayant plus de 20 amino-acidesGastrinesSomatostatinesMélanotropinesLeurs dérivés provenant d'humains provenant de vertébrés provenant de mammifères

18.

Process for Purifying Target Substances

      
Numéro d'application 17634679
Statut En instance
Date de dépôt 2020-08-06
Date de la première publication 2022-10-20
Propriétaire Fujifilm Diosynth Biotechnologies UK Limited (Royaume‑Uni)
Inventeur(s)
  • Nagy, Tibor
  • Haigh, Jonathan
  • Heise, Charles
  • Topping, Andrew
  • Pullen, James

Abrégé

A process for purifying a composition comprising water, a target substance, impurities and optionally cells, the process comprising the steps (A) and (B): (A) preparing a liquid feedstock by performing step (Ai) and/or (Aii) on the composition: (Ai) removing at least some of the cells from the composition; (Aii) concentrating the composition by removing water therefrom; and (B) passing the liquid feedstock through an apparatus comprising at least two processing units, each such unit producing a product stream containing purified target substance and optionally a waste stream comprising at least some of the impurities, wherein each unit comprises specified components (i) to (v). The units may be essentially the same except for a device they contain, leading to advantages in terms of simplicity, cost and ease of operation, lower risk of operator error, easier maintenance and lower inventory of spare parts.

Classes IPC  ?

  • C12M 1/00 - Appareillage pour l'enzymologie ou la microbiologie
  • B01D 61/14 - UltrafiltrationMicrofiltration
  • B01D 15/38 - Adsorption sélective, p. ex. chromatographie caractérisée par le mécanisme de séparation impliquant une interaction spécifique non couverte par un ou plusieurs des groupes , p. ex. chromatographie d'affinité, chromatographie d'échange par ligand ou chromatographie chirale
  • B01D 15/36 - Adsorption sélective, p. ex. chromatographie caractérisée par le mécanisme de séparation impliquant une interaction ionique, p. ex. échange d'ions, paire d'ions, suppression d'ions ou exclusion d'ions
  • B01D 15/18 - Adsorption sélective, p. ex. chromatographie caractérisée par des caractéristiques de structure ou de fonctionnement relatives aux différents types d'écoulement
  • C12M 1/34 - Mesure ou test par des moyens de mesure ou de détection des conditions du milieu, p. ex. par des compteurs de colonies

19.

Apparatus for Purifying a Liquid Comprising a Target Substance

      
Numéro d'application 17634692
Statut En instance
Date de dépôt 2020-08-06
Date de la première publication 2022-10-13
Propriétaire Fujifilm Diosynth Biotechnologies UK Limited (Royaume‑Uni)
Inventeur(s)
  • Nagy, Tibor
  • Haigh, Jonathan
  • Heise, Charles
  • Topping, Andrew
  • Pullen, James

Abrégé

Apparatus for purifying a liquid comprising a target substance comprising at least two units arranged in series such that the feed stream of the second and any subsequent units comprises the product stream from a downstream unit, wherein each unit comprises specified components (i) to (vi), including a a switchable bypass assembly. Also claimed are the units and a flowpath assembly. The units may be essentially the same except for a device they contain, leading to advantages in terms of simplicity, cost and ease of operation, lower risk of operator error, easier maintenance and lower inventory of spare parts.

Classes IPC  ?

  • C12M 1/00 - Appareillage pour l'enzymologie ou la microbiologie
  • B01D 15/18 - Adsorption sélective, p. ex. chromatographie caractérisée par des caractéristiques de structure ou de fonctionnement relatives aux différents types d'écoulement
  • B01D 15/16 - Adsorption sélective, p. ex. chromatographie caractérisée par des caractéristiques de structure ou de fonctionnement relatives au conditionnement du fluide vecteur
  • C07K 1/16 - ExtractionSéparationPurification par chromatographie

20.

Process for Purifying Monoclocal Antibodies

      
Numéro d'application 17634672
Statut En instance
Date de dépôt 2020-08-06
Date de la première publication 2022-09-01
Propriétaire Fujifilm Diosynth Biotechnologies UK Limited (Royaume‑Uni)
Inventeur(s)
  • Nagy, Tibor
  • Haigh, Jonathan
  • Heise, Charles
  • Topping, Andrew
  • Pullen, James

Abrégé

A process for purifying a liquid feedstock comprising a monoclonal antibody and impurities, the process comprising passing the liquid feedstock through an apparatus comprising at least two processing units, each such unit producing a product stream containing purified monoclonal antibody and optionally a waste stream comprising at least some of the impurities, wherein each unit comprises specified components (i) to (v) which include a multiple inlet flow-controller comprising two or more variable flow inlet valves for in situ production of a bioprocessing liquid by combining at least two liquids in a desired ratio. One of the units performs chromatography and another performs viral inactivation. The units may be essentially the same except for a device they contain, leading to advantages in terms of simplicity, cost and ease of operation, lower risk of operator error, easier maintenance and lower inventory of spare parts.

Classes IPC  ?

  • C07K 1/36 - ExtractionSéparationPurification par une combinaison de plusieurs procédés de types différents
  • C07K 1/34 - ExtractionSéparationPurification par filtration, ultrafiltration ou osmose inverse
  • C07K 1/22 - Chromatographie d'affinité ou techniques analogues basées sur des procédés d'absorption sélective
  • C07K 1/18 - Chromatographie d'échange d'ions
  • C07K 16/06 - Immunoglobulines, p. ex. anticorps monoclonaux ou polyclonaux provenant de sérum
  • B01D 15/14 - Adsorption sélective, p. ex. chromatographie caractérisée par des caractéristiques de structure ou de fonctionnement relatives à l'introduction de l'alimentation dans l'appareil
  • B01D 15/18 - Adsorption sélective, p. ex. chromatographie caractérisée par des caractéristiques de structure ou de fonctionnement relatives aux différents types d'écoulement
  • B01D 61/14 - UltrafiltrationMicrofiltration
  • B01D 15/38 - Adsorption sélective, p. ex. chromatographie caractérisée par le mécanisme de séparation impliquant une interaction spécifique non couverte par un ou plusieurs des groupes , p. ex. chromatographie d'affinité, chromatographie d'échange par ligand ou chromatographie chirale
  • B01D 15/36 - Adsorption sélective, p. ex. chromatographie caractérisée par le mécanisme de séparation impliquant une interaction ionique, p. ex. échange d'ions, paire d'ions, suppression d'ions ou exclusion d'ions

21.

Expression Process

      
Numéro d'application 17694760
Statut En instance
Date de dépôt 2022-03-15
Date de la première publication 2022-07-07
Propriétaire Fujifilm Diosynth Biotechnologies UK Limited (Royaume‑Uni)
Inventeur(s)
  • Saunders, Fay Louise
  • Dodds, Anna Louise
  • Bayard, Adeline Marie Geraldine
  • Kara, Bhupendra Vallabh

Abrégé

A process for the production of a target polypeptide is provided. The process comprises expression of an expression vector for expressing a target polypeptide in a host cell, preferably a mammalian cell, the expression vector comprising an expression cassette comprising a polynucleotide encoding a recombinant polypeptide operably linked to a fibronectin secretion leader sequence; and recovering the target polypeptide.

Classes IPC  ?

  • C12N 15/85 - Vecteurs ou systèmes d'expression spécialement adaptés aux hôtes eucaryotes pour cellules animales
  • C07K 16/06 - Immunoglobulines, p. ex. anticorps monoclonaux ou polyclonaux provenant de sérum
  • C07K 16/30 - Immunoglobulines, p. ex. anticorps monoclonaux ou polyclonaux contre du matériel provenant d'animaux ou d'humains contre des récepteurs, des antigènes de surface cellulaire ou des déterminants de surface cellulaire provenant de cellules de tumeurs

22.

MARUX

      
Numéro d'application 1650960
Statut Enregistrée
Date de dépôt 2020-11-09
Date d'enregistrement 2020-11-09
Propriétaire FUJIFILM Diosynth Biotechnologies UK Limited (Royaume‑Uni)
Classes de Nice  ?
  • 40 - Traitement de matériaux; recyclage, purification de l'air et traitement de l'eau
  • 42 - Services scientifiques, technologiques et industriels, recherche et conception

Produits et services

Continuous production, including continuous manufacture and purification, of biological products such as cells, viruses and biomolecules, including genes and proteins, obtained from recombinant cells, to the order and specification of others; continuous expression, isolation and purification, of biological products such as cells, viruses and biomolecules, including genes and proteins, obtained from recombinant cells, to the order and specification of others; continuous connected upstream and downstream production of biological products such as cells, viruses and biomolecules, including genes and proteins, obtained from recombinant cells, to the order and specification of others. Scientific, industrial and technical research, development and analysis services related to continuous production, including continuous manufacture and purification, of biological products such as such as cells, viruses and biomolecules, including genes and proteins, obtained from recombinant cells; process development related to the continuous production, including continuous manufacture and purification, of biological products such as such as cells, viruses and biomolecules, including genes and proteins, obtained from recombinant cells; industrial design services related to the continuous production, including continuous manufacture and purification, of biological products such as such as cells, viruses and biomolecules, including genes and proteins, obtained from recombinant cells; provision of facilities for scientific, industrial and technical research development related to the continuous production, including continuous manufacture and purification, of biological products such as such as cells, viruses and biomolecules, including genes and proteins, obtained from recombinant cells.

23.

Static Mixer

      
Numéro d'application 17293541
Statut En instance
Date de dépôt 2019-11-13
Date de la première publication 2022-01-06
Propriétaire Fujifilm Diosynth Biotechnologies UK Limited (Royaume‑Uni)
Inventeur(s) Heise, Charles

Abrégé

A static mixing apparatus for mixing a fluid, preferably a liquid is provided. The mixer comprises a plurality of chambers (5, 8, 12, 15) in series, the first chamber (5) of the series comprising a fluid inlet (4), and the final chamber (15) of the series comprising a fluid outlet (16), each chamber other than the final chamber in the series being in fluid connection with a subsequent chamber, the fluid connection comprising a plurality of orifices (7, 10, 11, 14) dispersed along a direction of flow, the nearest point to the fluid inlet of each subsequent orifice to the inlet overlapping with the furthest point from the fluid inlet of the previous orifice, and being off-set along the direction of flow from the previous orifice.

Classes IPC  ?

  • B01F 5/06 - Mélangeurs dans lesquels les composants du mélange sont pressés ensemble au travers de fentes, d'orifices, ou de tamis

24.

Tangential flow filtration process for concentrating biomolecule solutions

      
Numéro d'application 17152874
Numéro de brevet 11685765
Statut Délivré - en vigueur
Date de dépôt 2021-01-20
Date de la première publication 2021-06-03
Date d'octroi 2023-06-27
Propriétaire Fujifilm Diosynth Biotechnologies UK Limited (Royaume‑Uni)
Inventeur(s)
  • Heise, Charles
  • Nagy, Tibor

Abrégé

A method of concentration of a liquid comprising a biomolecule is provided. The method comprises passing the liquid through a tangential flow filtration device under pressure, wherein the pressure applied is varied between at least a higher pressure and a lower pressure. Preferably, the variation in pressure is delivered by the use of a variable flow-controller, such as a valve.

Classes IPC  ?

  • C07K 1/34 - ExtractionSéparationPurification par filtration, ultrafiltration ou osmose inverse

25.

APPARATUS FOR PURIFYING A LIQUID COMPRISING A TARGET SUBSTANCE

      
Numéro de document 03149944
Statut En instance
Date de dépôt 2020-08-06
Date de disponibilité au public 2021-02-18
Propriétaire FUJIFILM DIOSYNTH BIOTECHNOLOGIES UK LIMITED (Royaume‑Uni)
Inventeur(s)
  • Nagy, Tibor
  • Haigh, Jonathan
  • Heise, Charles
  • Topping, Andrew
  • Pullen, James

Abrégé

Apparatus for purifying a liquid comprising a target substance comprising at least two units arranged in series such that the feed stream of the second and any subsequent units comprises the product stream from a downstream unit, wherein each unit comprises specified components (i) to (vi), including a a switchable bypass assembly. Also claimed are the units and a flowpath assembly. The units may be essentially the same except for a device they contain, leading to advantages in terms of simplicity, cost and ease of operation, lower risk of operator error, easier maintenance and lower inventory of spare parts.

Classes IPC  ?

  • B01D 15/18 - Adsorption sélective, p. ex. chromatographie caractérisée par des caractéristiques de structure ou de fonctionnement relatives aux différents types d'écoulement
  • C07K 1/14 - ExtractionSéparationPurification
  • C12N 15/10 - Procédés pour l'isolement, la préparation ou la purification d'ADN ou d'ARN
  • B01D 15/16 - Adsorption sélective, p. ex. chromatographie caractérisée par des caractéristiques de structure ou de fonctionnement relatives au conditionnement du fluide vecteur
  • C12M 1/00 - Appareillage pour l'enzymologie ou la microbiologie

26.

PROCESS FOR PURIFYING MONOCLONAL ANTIBODIES

      
Numéro d'application GB2020051882
Numéro de publication 2021/028658
Statut Délivré - en vigueur
Date de dépôt 2020-08-06
Date de publication 2021-02-18
Propriétaire FUJIFILM DIOSYNTH BIOTECHNOLOGIES UK LIMITED (Royaume‑Uni)
Inventeur(s)
  • Nagy, Tibor
  • Haigh, Jonathan
  • Heise, Charles
  • Topping, Andrew
  • Pullen, James

Abrégé

in situin situ production of a bioprocessing liquid by combining at least two liquids in a desired ratio. One of the units performs chromatography and another performs viral inactivation. The units may be essentially the same except for a device they contain, leading to advantages in terms of simplicity, cost and ease of operation, lower risk of operator error, easier maintenance and lower inventory of spare parts.

Classes IPC  ?

  • G01N 30/34 - Contrôle des paramètres physiques du fluide vecteur de la composition du fluide, p. ex. du gradient
  • B01D 15/36 - Adsorption sélective, p. ex. chromatographie caractérisée par le mécanisme de séparation impliquant une interaction ionique, p. ex. échange d'ions, paire d'ions, suppression d'ions ou exclusion d'ions
  • B01D 15/38 - Adsorption sélective, p. ex. chromatographie caractérisée par le mécanisme de séparation impliquant une interaction spécifique non couverte par un ou plusieurs des groupes , p. ex. chromatographie d'affinité, chromatographie d'échange par ligand ou chromatographie chirale
  • C07K 1/16 - ExtractionSéparationPurification par chromatographie
  • C07K 1/36 - ExtractionSéparationPurification par une combinaison de plusieurs procédés de types différents
  • C12N 7/04 - Inactivation ou atténuationProduction de parties élémentaires de virus
  • C12N 15/10 - Procédés pour l'isolement, la préparation ou la purification d'ADN ou d'ARN

27.

PROCESS FOR PURIFYING TARGET SUBSTANCES

      
Numéro d'application GB2020051884
Numéro de publication 2021/028660
Statut Délivré - en vigueur
Date de dépôt 2020-08-06
Date de publication 2021-02-18
Propriétaire FUJIFILM DIOSYNTH BIOTECHNOLOGIES UK LIMITED (Royaume‑Uni)
Inventeur(s)
  • Nagy, Tibor
  • Haigh, Jonathan
  • Heise, Charles
  • Topping, Andrew
  • Pullen, James

Abrégé

A process for purifying a composition comprising water, a target substance, impurities and optionally cells, the process comprising the steps (A) and (B): (A) preparing a liquid feedstock by performing step (Ai) and/or (Aii) on the composition: (Ai) removing at least some of the cells from the composition; (Aii) concentrating the composition by removing water therefrom; and (B) passing the liquid feedstock through an apparatus comprising at least two processing units, each such unit producing a product stream containing purified target substance and optionally a waste stream comprising at least some of the impurities, wherein each unit comprises specified components (i) to (v). The units may be essentially the same except for a device they contain, leading to advantages in terms of simplicity, cost and ease of operation, lower risk of operator error, easier maintenance and lower inventory of spare parts.

Classes IPC  ?

  • B01D 15/18 - Adsorption sélective, p. ex. chromatographie caractérisée par des caractéristiques de structure ou de fonctionnement relatives aux différents types d'écoulement
  • C07K 1/36 - ExtractionSéparationPurification par une combinaison de plusieurs procédés de types différents
  • C12M 1/00 - Appareillage pour l'enzymologie ou la microbiologie
  • C12N 15/10 - Procédés pour l'isolement, la préparation ou la purification d'ADN ou d'ARN
  • G01N 30/34 - Contrôle des paramètres physiques du fluide vecteur de la composition du fluide, p. ex. du gradient
  • G01N 30/46 - Modèles d'écoulement utilisant plus d'une colonne
  • B01D 15/16 - Adsorption sélective, p. ex. chromatographie caractérisée par des caractéristiques de structure ou de fonctionnement relatives au conditionnement du fluide vecteur

28.

APPARATUS FOR PURIFYING A LIQUID COMPRISING A TARGET SUBSTANCE

      
Numéro d'application GB2020051888
Numéro de publication 2021/028663
Statut Délivré - en vigueur
Date de dépôt 2020-08-06
Date de publication 2021-02-18
Propriétaire FUJIFILM DIOSYNTH BIOTECHNOLOGIES UK LIMITED (Royaume‑Uni)
Inventeur(s)
  • Nagy, Tibor
  • Haigh, Jonathan
  • Heise, Charles
  • Topping, Andrew
  • Pullen, James

Abrégé

Apparatus for purifying a liquid comprising a target substance comprising at least two units arranged in series such that the feed stream of the second and any subsequent units comprises the product stream from a downstream unit, wherein each unit comprises specified components (i) to (vi), including a a switchable bypass assembly. Also claimed are the units and a flowpath assembly. The units may be essentially the same except for a device they contain, leading to advantages in terms of simplicity, cost and ease of operation, lower risk of operator error, easier maintenance and lower inventory of spare parts.

Classes IPC  ?

  • G01N 30/34 - Contrôle des paramètres physiques du fluide vecteur de la composition du fluide, p. ex. du gradient
  • G01N 30/46 - Modèles d'écoulement utilisant plus d'une colonne
  • C07K 1/36 - ExtractionSéparationPurification par une combinaison de plusieurs procédés de types différents
  • C12N 15/10 - Procédés pour l'isolement, la préparation ou la purification d'ADN ou d'ARN
  • B01D 15/18 - Adsorption sélective, p. ex. chromatographie caractérisée par des caractéristiques de structure ou de fonctionnement relatives aux différents types d'écoulement
  • C12M 1/00 - Appareillage pour l'enzymologie ou la microbiologie
  • B01D 15/16 - Adsorption sélective, p. ex. chromatographie caractérisée par des caractéristiques de structure ou de fonctionnement relatives au conditionnement du fluide vecteur

29.

Apparatus for processing a liquid comprising a target substance

      
Numéro d'application 16969690
Numéro de brevet 12216098
Statut Délivré - en vigueur
Date de dépôt 2019-02-11
Date de la première publication 2021-02-04
Date d'octroi 2025-02-04
Propriétaire Fujifilm Diosynth Biotechnologies UK Limited (Royaume‑Uni)
Inventeur(s)
  • Heise, Charles
  • Haigh, Jonathan
  • Nagy, Tibor
  • Pullen, James
  • Topping, Andrew

Abrégé

Apparatus for processing a liquid comprising a target substance, preferably a biomolecule, is provided. The apparatus comprises at least a first and a second means for carrying out a unit operation, each means for carrying out a unit operation comprising a feed for a liquid in fluid connection with the inlet of a flow-controller comprising a variable flow inlet valve and an outlet, wherein at least one of the means for carrying out a unit operation comprises feeds for at least two liquids, the feeds being in fluid connection with the inlets of a multiple inlet flow-controller comprising two or more variable flow inlet valves for dosing the at least two liquids, the flow-controller also comprising an outlet; a feed for a liquid feedstock comprising the target substance in fluid connection with the outlet from the flow-controller thereby to enable combination of the feed for a liquid comprising the target substance with the mixed bioprocessing liquids to produce a device feed; a device for achieving a processing operation comprising a device inlet and a device outlet, the device inlet being in fluid connection with the device feed; and a means for imparting flow through the flow controller and from the feed for the liquid feedstock through the processing device via the device inlet; and wherein the feed for a liquid feedstock comprising the target substance for the second means for carrying out a unit operation comprises the outlet from the first means for carrying out a unit operation.

Classes IPC  ?

  • G01N 30/46 - Modèles d'écoulement utilisant plus d'une colonne
  • C07K 1/34 - ExtractionSéparationPurification par filtration, ultrafiltration ou osmose inverse
  • C12N 15/10 - Procédés pour l'isolement, la préparation ou la purification d'ADN ou d'ARN
  • G01N 30/34 - Contrôle des paramètres physiques du fluide vecteur de la composition du fluide, p. ex. du gradient

30.

SYMPHONX

      
Numéro d'application 1570692
Statut Enregistrée
Date de dépôt 2020-07-09
Date d'enregistrement 2020-07-09
Propriétaire FUJIFILM Diosynth Biotechnologies UK Limited (Royaume‑Uni)
Classes de Nice  ?
  • 09 - Appareils et instruments scientifiques et électriques
  • 11 - Appareils de contrôle de l'environnement
  • 40 - Traitement de matériaux; recyclage, purification de l'air et traitement de l'eau
  • 42 - Services scientifiques, technologiques et industriels, recherche et conception

Produits et services

Apparatus for use in separation and purification, including separation and purification of biological products such as cells, viruses and biomolecules, including genes and proteins; liquid chromatography apparatus for laboratory or scientific use; ion exchange apparatus for laboratory or scientific use; ultrafiltration apparatus for laboratory or scientific use; diafiltration apparatus for laboratory or scientific use; apparatus for diluting or concentrating biological products for laboratory or scientific use; apparatus for removal of viruses from solutions, including biological products, for laboratory or scientific use; apparatus for inactivation of viruses from solutions for laboratory or scientific use; apparatus for membrane filtration for laboratory or scientific use; apparatus for performing chromatographic separations and parts thereof for laboratory or scientific use; flowpaths, parts and fittings, including tubing, valves, in-line mixers, pressure sensors, temperature sensors and/or other sensors for all the aforesaid goods; computer software for control of the aforesaid goods; computer software for management of biological product purification processes. Apparatus for use in separation and purification for industrial purposes, including separation and purification of biological products such as cells, viruses and biomolecules, including genes and proteins; liquid chromatography apparatus for industrial purposes; ion exchange apparatus for industrial purposes; ultrafiltration apparatus for industrial purposes; diafiltration apparatus for industrial purposes; apparatus for diluting or concentrating biological products for industrial purposes; apparatus for removal of viruses from solutions, including biological products for industrial purposes; apparatus for inactivation of viruses from solutions for industrial purposes; apparatus for membrane filtration for industrial purposes; apparatus for performing chromatographic separations and parts thereof for industrial purposes; flowpaths, parts and fittings, including tubing, valves, in-line mixers, pressure sensors, temperature sensors and/or other sensors for all the aforesaid goods. Processing and manufacturing of biological products such as cells, viruses and biomolecules, including genes and proteins, including to the order and specification of others; manufacture, processing and production of biomolecules such as cells, viruses and biomolecules, including genes and proteins, to the order and specification of others. Scientific, industrial and technical research, development and analysis services related to biological products such as such as cells, viruses and biomolecules, including genes and proteins; process development related to the manufacture and purification of biological products such as such as cells, viruses and biomolecules, including genes and proteins; industrial design services related to the manufacture and purification of biological products such as such as cells, viruses and biomolecules, including genes and proteins; provision of facilities for scientific, industrial and technical research development related to the manufacture and purification of biological products such as such as cells, viruses and biomolecules, including genes and proteins.

31.

Expression system

      
Numéro d'application 16497102
Numéro de brevet 11479776
Statut Délivré - en vigueur
Date de dépôt 2018-03-14
Date de la première publication 2021-01-07
Date d'octroi 2022-10-25
Propriétaire Fujifilm Diosynth Biotechnologies UK Limited (Royaume‑Uni)
Inventeur(s) Lennon, Christopher

Abrégé

A protein expression system for use in a prokaryotic host is provided, the expression system comprising: a) an expression cassette comprising a nucleic acid sequence encoding a protein of interest operably linked to a T7 RNA polymerase-dependent promoter; and b) an expression cassette comprising a nucleic acid sequence encoding T7 RNA polymerase operably linked to a host polymerase-dependent λ phage promoter and a single perfect palindrome operator sequence; wherein the expression cassette for T7 RNA polymerase is located on the chromosome of a host cell.

Classes IPC  ?

  • C12N 15/73 - Systèmes d'expression utilisant des séquences régulatrices du phage lambda
  • C12N 9/12 - Transférases (2.) transférant des groupes contenant du phosphore, p. ex. kinases (2.7)
  • C12N 15/72 - Systèmes d'expression utilisant des séquences régulatrices dérivées de l'opéron lac

32.

MARUX

      
Numéro de série 79336145
Statut Enregistrée
Date de dépôt 2020-11-09
Date d'enregistrement 2023-02-28
Propriétaire FUJIFILM Diosynth Biotechnologies UK Limited (Royaume‑Uni)
Classes de Nice  ?
  • 40 - Traitement de matériaux; recyclage, purification de l'air et traitement de l'eau
  • 42 - Services scientifiques, technologiques et industriels, recherche et conception

Produits et services

Continuous, custom production or manufacture, namely continuous extraction, and purification, of biological products in the nature of cells, viruses and biomolecules, genes and proteins, obtained from recombinant cells, to the order and specification of others; Continuous, custom manufacture, namely continuous expression isolation, and purification, of biological products in the nature of cells, viruses and biomolecules, genes and proteins, obtained from recombinant cells, to the order and specification of others; Continuous, custom production or manufacture, namely, continuous connected upstream and downstream manufacture of biological products in the nature of cells, viruses and biomolecules, genes and proteins, obtained from recombinant cells, to the order and specification of others Scientific, industrial and technical research, development and analysis services related to continuous production, continuous manufacture and purification, of biological products in the nature of cells, viruses and biomolecules, genes and proteins, obtained from recombinant cells; Scientific research and development, namely process development related to the continuous production, continuous manufacture and purification, of biological products in the nature of cells, viruses and biomolecules, genes and proteins, obtained from recombinant cells; Industrial design services related to the continuous production, continuous manufacture and purification, of biological in the nature of cells, viruses and biomolecules, genes and proteins, obtained from recombinant cells; Provision of facilities for scientific, industrial and technical research development related to the continuous production, continuous manufacture and purification, of biological products in the nature of cells, viruses and biomolecules, genes and proteins, obtained from recombinant cells

33.

Method for processing solutions of biomolecules

      
Numéro d'application 16864234
Numéro de brevet 11439956
Statut Délivré - en vigueur
Date de dépôt 2020-05-01
Date de la première publication 2020-08-27
Date d'octroi 2022-09-13
Propriétaire Fujifilm Diosynth Biotechnologies UK Limited (Royaume‑Uni)
Inventeur(s)
  • Heise, Charles
  • Nagy, Tibor

Abrégé

Apparatus for in-line liquid exchanging a biomolecule-containing liquid is provided. The apparatus comprises a means for mixing at least two liquids comprising a multiple inlet flow-controller, the means for mixing also comprising an outlet in fluid connection with a tangential flow filtration device configured in single-pass mode.

Classes IPC  ?

  • B01D 61/18 - Appareils à cet effet
  • B01D 61/20 - AccessoiresOpérations auxiliaires
  • C07K 1/14 - ExtractionSéparationPurification
  • C12N 15/10 - Procédés pour l'isolement, la préparation ou la purification d'ADN ou d'ARN
  • B01D 61/14 - UltrafiltrationMicrofiltration
  • B01D 61/16 - Prétraitement du courant d'alimentation
  • B01D 61/22 - Commande ou régulation

34.

Method for preparing aqueous solutions of a defined pH

      
Numéro d'application 16652204
Numéro de brevet 11911712
Statut Délivré - en vigueur
Date de dépôt 2018-09-21
Date de la première publication 2020-07-30
Date d'octroi 2024-02-27
Propriétaire Fujifilm Diosynth Biotechnologies UK Limited (Royaume‑Uni)
Inventeur(s) Nagy, Tibor

Abrégé

A method for preparing an aqueous solution of a defined pH comprising an acid, a base and optionally one or more additives is provided. The method comprises the steps of: a) calculating the theoretical concentrations of acid and base for the solution to have the defined pH using the Henderson-Hasselbach equation in combination with the Debye Huckel theory for a range of different additive concentrations; b) preparing a sample of the buffer for the range of additive concentrations and measuring the actual pH for each additive concentration; c) calculating a value for delta pH, ΔpH, being the difference between the theoretical pH and the actual pH, for each additive concentration; d) generating a mathematical model describing the relationship of ΔpH with additive concentration; e) selecting the defined pH and additive concentrations; f) using the mathematical model generated in step d) to calculate ΔpH for the defined pH and additive concentration; g) calculating a ΔpH-corrected pH by summing the defined pH and delta pH; h) using the ΔpH-corrected pH to calculate the concentrations of acid and base using the Henderson-Hasselbach equation in combination with the Debye Huckel theory; i) preparing the solution using the concentrations calculated in step h).

Classes IPC  ?

  • B01D 15/16 - Adsorption sélective, p. ex. chromatographie caractérisée par des caractéristiques de structure ou de fonctionnement relatives au conditionnement du fluide vecteur
  • G01N 30/34 - Contrôle des paramètres physiques du fluide vecteur de la composition du fluide, p. ex. du gradient
  • G05D 21/02 - Commande des variables chimiques ou physico-chimiques, p. ex. de la valeur du pH caractérisée par l'utilisation de moyens électriques
  • B01F 25/42 - Mélangeurs statiques dans lesquels le mélange est affecté par le déplacement conjoint des composants dans des directions différentes, p. ex. dans des tubes munis de chicanes ou d'obstructions
  • B01F 35/221 - Commande ou régulation des paramètres de fonctionnement, p. ex. du niveau de matière dans le mélangeur, de la température ou de la pression
  • B01F 35/71 - Mécanismes d'alimentation

35.

SYMPHONX

      
Numéro de série 79302302
Statut Enregistrée
Date de dépôt 2020-07-09
Date d'enregistrement 2022-06-07
Propriétaire FUJIFILM Diosynth Biotechnologies UK Limited (Royaume‑Uni)
Classes de Nice  ?
  • 09 - Appareils et instruments scientifiques et électriques
  • 11 - Appareils de contrôle de l'environnement
  • 40 - Traitement de matériaux; recyclage, purification de l'air et traitement de l'eau
  • 42 - Services scientifiques, technologiques et industriels, recherche et conception

Produits et services

Fluid processing system for use in the separation and purification of biological products such as cells, viruses and biomolecules, including nucleic acids and proteins, for bioprocessing and pharmaceutical research, comprised primarily of chromatography apparatus for laboratory use, laboratory filters, and fluid handling devices used for bioprocessing applications and component parts and fittings; Liquid chromatography apparatus for laboratory use; Ion exchange chromatography apparatus for the treatment of fluids for laboratory use; Ultrafiltration apparatus for laboratory or scientific research use, namely, ultrafiltration laboratory filters and laboratory ultrafiltration filter membranes as part of scientific apparatus; Diafiltration apparatus for laboratory or scientific research use, namely, laboratory diafiltration filters; Scientific, laboratory, and measuring apparatus and instruments for diluting or concentrating biological products for laboratory or scientific research use, namely, tangential flow filtration devices for preparation of biological samples for use in the biopharmaceutical industry; Laboratory filters in the nature of viral filtration apparatus for removal of viruses from solutions for laboratory or scientific research use; Membrane filtration apparatus in the nature of membrane laboratory filters for use in laboratory equipment in the biopharmaceutical industry for treating biological fluids and solutions; Chromatography apparatus and component parts thereof for laboratory or scientific research use; Parts and fittings, namely, tubing, valves, in-line mixers, pressure sensors, temperature sensors and electronic sensors specially adapted for use with all of the aforementioned goods; Computer software for control of the aforesaid goods, namely, downloadable and recorded software for operating a fluid processing apparatus for laboratory or scientific research use comprising chromatography, membrane filtration, tangential flow filtration, viral filtration, ultrafiltration, diafiltration, viral filtration, viral inactivation, in-line conditioning, and buffer management components and systems; Computer software for management of biological product purification processes, namely, downloadable and recorded software for managing the purification of cells, viruses, and biomolecules in the nature of nucleic acids and proteins Fluid processing system apparatus and system for use in the separation and purification of biological products such as cells, viruses and biomolecules, including nucleic acids and proteins, for the pharmaceutical and biomanufacturing industries, namely, chromatography apparatus for industrial use and apparatus and instruments for use in the purification, conditioning, separation and sterilization of liquids and gases used in the biotechnology, pharmaceutical, medical, and biopharmaceutical industries; Liquid chromatography apparatus for industrial purposes; Ion exchange apparatus for the treatment of fluids for industrial purposes; Ultrafiltration apparatus for industrial purposes, namely, apparatus and instruments for use in the purification, separation and sterilization of liquids and gases used in the biotechnology, pharmaceutical, medical, and biopharmaceutical industries; Diafiltration apparatus, namely, aqueous solution filtering systems and components and biological fluid filtering systems and components for industrial purposes being apparatus and instruments for use in the purification, separation and sterilization of liquids used in the biotechnology, pharmaceutical, medical, and biopharmaceutical industries; Apparatus for diluting or concentrating biological products for industrial purposes, namely, tangential flow filtration apparatus being apparatus for use in the purification, separation and sterilization of liquids and gases used in the biotechnology, pharmaceutical, medical, and biopharmaceutical industries; Viral filtration apparatus for removal of viruses from solutions for industrial purposes, namely, apparatus and instruments for use in the purification, separation and sterilization of liquids and gases used in the biotechnology, pharmaceutical, medical, and biopharmaceutical industries; Virus inactivation and disinfection apparatus for the treatment of biological products in the field of biomanufacturing and pharmaceuticals, all for industrial purposes in the nature of apparatus and instruments for use in the purification, separation and sterilization of liquids and gases used in the biotechnology, pharmaceutical, medical, and biopharmaceutical industries; Membrane filtration apparatus for industrial purposes in the nature of membrane filter cartridges for the separation of biomolecules in biopharmaceutical production; Chromatography apparatus for industrial purposes and component parts thereof; Parts and fittings, namely, tubing, valves, in-line mixers, pressure sensors, temperature sensors and electric sensors, specially adapted for use with the aforementioned Processing and manufacturing of biological products such as cells, viruses and biomolecules, including genes and proteins, namely, manufacturing of pharmaceuticals using biological organisms in the manufacturing process to the order and specification of others; Manufacture of biomolecules such as cells, viruses and biomolecules, including genes and proteins, to the order and specification of others Scientific research, industrial biomedical research and technical product research and development services in the field of biomanufacturing, bioprocessing and pharmaceuticals related to biological products such as cells, viruses and biomolecules, including nucleic acids and proteins; Process development services related to the manufacture and purification of biological products such as such as cells, viruses and biomolecules, including nucleic acids and proteins, namely, biomedical and pharmaceutical research; Industrial design services related to the manufacture and purification of biological products such as cells, viruses and biomolecules, including nucleic acids and proteins; Provision of facilities for scientific, industrial and technical research and development in the field of biomanufacturing, bioprocessing and pharmaceuticals, namely, scientific laboratory services

36.

STATIC MIXER

      
Numéro d'application GB2019053213
Numéro de publication 2020/099865
Statut Délivré - en vigueur
Date de dépôt 2019-11-13
Date de publication 2020-05-22
Propriétaire FUJIFILM DIOSYNTH BIOTECHNOLOGIES UK LIMITED (Royaume‑Uni)
Inventeur(s) Heise, Charles

Abrégé

A static mixing apparatus for mixing a fluid, preferably a liquid is provided. The mixer comprises a plurality of chambers (5, 8, 12, 15) in series, the first chamber (5) of the series comprising a fluid inlet (4), and the final chamber (15) of the series comprising a fluid outlet (16), each chamber other than the final chamber in the series being in fluid connection with a subsequent chamber, the fluid connection comprising a plurality of orifices (7, 10, 11, 14) dispersed along a direction of flow, the nearest point to the fluid inlet of each subsequent orifice to the inlet overlapping with the furthest point from the fluid inlet of the previous orifice, and being off-set along the direction of flow from the previous orifice.

Classes IPC  ?

  • B01F 5/06 - Mélangeurs dans lesquels les composants du mélange sont pressés ensemble au travers de fentes, d'orifices, ou de tamis

37.

APPARATUS FOR PROCESSING A LIQUID COMPRISING A TARGET SUBSTANCE

      
Numéro de document 03090613
Statut En instance
Date de dépôt 2019-02-11
Date de disponibilité au public 2019-08-22
Propriétaire FUJIFILM DIOSYNTH BIOTECHNOLOGIES UK LIMITED (Royaume‑Uni)
Inventeur(s)
  • Heise, Charles
  • Haigh, Jonathan
  • Nagy, Tibor
  • Pullen, James
  • Topping, Andrew

Abrégé

Apparatus for processing a liquid comprising a target substance, preferably a biomolecule, is provided. The apparatus comprises at least a first and a second means for carrying out a unit operation, each means for carrying out a unit operation comprising a feed for a liquid in fluid connection with the inlet of a flow-controller comprising a variable flow inlet valve and an outlet, wherein at least one of the means for carrying out a unit operation comprises feeds for at least two liquids, the feeds being in fluid connection with the inlets of a multiple inlet flow-controller comprising two or more variable flow inlet valves for dosing the at least two liquids, the flow-controller also comprising an outlet; a feed for a liquid feedstock comprising the target substance in fluid connection with the outlet from the flow-controller thereby to enable combination of the feed for a liquid comprising the target substance with the mixed bioprocessing liquids to produce a device feed; a device for achieving a processing operation comprising a device inlet and a device outlet, the device inlet being in fluid connection with the device feed; and a means for imparting flow through the flow controller and from the feed for the liquid feedstock through the processing device via the device inlet; and wherein the feed for a liquid feedstock comprising the target substance for the second means for carrying out a unit operation comprises the outlet from the first means for carrying out a unit operation.

Classes IPC  ?

  • C07K 1/16 - ExtractionSéparationPurification par chromatographie
  • C12N 15/10 - Procédés pour l'isolement, la préparation ou la purification d'ADN ou d'ARN
  • G01N 30/34 - Contrôle des paramètres physiques du fluide vecteur de la composition du fluide, p. ex. du gradient
  • G01N 30/46 - Modèles d'écoulement utilisant plus d'une colonne
  • B01D 61/14 - UltrafiltrationMicrofiltration
  • C07K 1/34 - ExtractionSéparationPurification par filtration, ultrafiltration ou osmose inverse

38.

APPARATUS FOR PROCESSING A LIQUID COMPRISING A TARGET SUBSTANCE

      
Numéro d'application GB2019050351
Numéro de publication 2019/158906
Statut Délivré - en vigueur
Date de dépôt 2019-02-11
Date de publication 2019-08-22
Propriétaire FUJIFILM DIOSYNTH BIOTECHNOLOGIES UK LIMITED (Royaume‑Uni)
Inventeur(s)
  • Heise, Charles
  • Haigh, Jonathan
  • Nagy, Tibor
  • Pullen, James
  • Topping, Andrew

Abrégé

Apparatus for processing a liquid comprising a target substance, preferably a biomolecule, is provided. The apparatus comprises at least a first and a second means for carrying out a unit operation, each means for carrying out a unit operation comprising a feed for a liquid in fluid connection with the inlet of a flow-controller comprising a variable flow inlet valve and an outlet, wherein at least one of the means for carrying out a unit operation comprises feeds for at least two liquids, the feeds being in fluid connection with the inlets of a multiple inlet flow-controller comprising two or more variable flow inlet valves for dosing the at least two liquids, the flow-controller also comprising an outlet; a feed for a liquid feedstock comprising the target substance in fluid connection with the outlet from the flow-controller thereby to enable combination of the feed for a liquid comprising the target substance with the mixed bioprocessing liquids to produce a device feed; a device for achieving a processing operation comprising a device inlet and a device outlet, the device inlet being in fluid connection with the device feed; and a means for imparting flow through the flow controller and from the feed for the liquid feedstock through the processing device via the device inlet; and wherein the feed for a liquid feedstock comprising the target substance for the second means for carrying out a unit operation comprises the outlet from the first means for carrying out a unit operation.

Classes IPC  ?

  • C07K 1/16 - ExtractionSéparationPurification par chromatographie
  • C12N 15/10 - Procédés pour l'isolement, la préparation ou la purification d'ADN ou d'ARN
  • G01N 30/46 - Modèles d'écoulement utilisant plus d'une colonne
  • G01N 30/34 - Contrôle des paramètres physiques du fluide vecteur de la composition du fluide, p. ex. du gradient
  • C07K 1/34 - ExtractionSéparationPurification par filtration, ultrafiltration ou osmose inverse
  • B01D 61/14 - UltrafiltrationMicrofiltration

39.

METHOD FOR PREPARING AQUEOUS SOLUTIONS OF A DEFINED PH

      
Numéro de document 03078417
Statut En instance
Date de dépôt 2018-09-21
Date de disponibilité au public 2019-04-11
Propriétaire FUJIFILM DIOSYNTH BIOTECHNOLOGIES UK LIMITED (Royaume‑Uni)
Inventeur(s) Nagy, Tibor

Abrégé

A method for preparing an aqueous solution of a defined pH comprising an acid, a base and optionally one or more additives is provided. The method comprises the steps of: a) calculating the theoretical concentrations of acid and base for the solution to have the defined pH using the Henderson-Hasselbach equation in combination with the Debye Huckel theory for a range of different additive concentrations; b) preparing a sample of the buffer for the range of additive concentrations and measuring the actual pH for each additive concentration; c) calculating a value for delta pH, ?pH, being the difference between the theoretical pH and the actual pH, for each additive concentration; d) generating a mathematical model describing the relationship of ?pH with additive concentration; e) selecting the defined pH and additive concentrations;f) using the mathematical model generated in step d) to calculate ?pH for the defined pH and additive concentration; g) calculating a ?pH-corrected pH by summing the defined pH and delta pH; h) using the ?pH-corrected pH to calculate the concentrations of acid and base using the Henderson-Hasselbach equation in combination with the Debye Huckel theory; i) preparing the solution using the concentrations calculated in step h).

Classes IPC  ?

  • G01N 30/34 - Contrôle des paramètres physiques du fluide vecteur de la composition du fluide, p. ex. du gradient
  • B01J 47/15 - Commande ou régulation pour l’obtention d’une solution ayant un pH fixe
  • B01D 15/16 - Adsorption sélective, p. ex. chromatographie caractérisée par des caractéristiques de structure ou de fonctionnement relatives au conditionnement du fluide vecteur
  • G05D 21/02 - Commande des variables chimiques ou physico-chimiques, p. ex. de la valeur du pH caractérisée par l'utilisation de moyens électriques

40.

METHOD FOR PREPARING AQUEOUS SOLUTIONS OF A DEFINED PH

      
Numéro d'application GB2018052687
Numéro de publication 2019/069046
Statut Délivré - en vigueur
Date de dépôt 2018-09-21
Date de publication 2019-04-11
Propriétaire FUJIFILM DIOSYNTH BIOTECHNOLOGIES UK LIMITED (Royaume‑Uni)
Inventeur(s) Nagy, Tibor

Abrégé

A method for preparing an aqueous solution of a defined pH comprising an acid, a base and optionally one or more additives is provided. The method comprises the steps of: a) calculating the theoretical concentrations of acid and base for the solution to have the defined pH using the Henderson-Hasselbach equation in combination with the Debye Huckel theory for a range of different additive concentrations; b) preparing a sample of the buffer for the range of additive concentrations and measuring the actual pH for each additive concentration; c) calculating a value for delta pH, ∆pH, being the difference between the theoretical pH and the actual pH, for each additive concentration; d) generating a mathematical model describing the relationship of ∆pH with additive concentration; e) selecting the defined pH and additive concentrations;f) using the mathematical model generated in step d) to calculate ∆pH for the defined pH and additive concentration; g) calculating a ∆pH-corrected pH by summing the defined pH and delta pH; h) using the ∆pH-corrected pH to calculate the concentrations of acid and base using the Henderson-Hasselbach equation in combination with the Debye Huckel theory; i) preparing the solution using the concentrations calculated in step h).

Classes IPC  ?

  • G01N 30/34 - Contrôle des paramètres physiques du fluide vecteur de la composition du fluide, p. ex. du gradient
  • G05D 21/02 - Commande des variables chimiques ou physico-chimiques, p. ex. de la valeur du pH caractérisée par l'utilisation de moyens électriques
  • B01J 47/15 - Commande ou régulation pour l’obtention d’une solution ayant un pH fixe
  • B01D 15/16 - Adsorption sélective, p. ex. chromatographie caractérisée par des caractéristiques de structure ou de fonctionnement relatives au conditionnement du fluide vecteur

41.

Tangential flow filtration process for concentrating biomolecule solutions

      
Numéro d'application 16068387
Numéro de brevet 10934325
Statut Délivré - en vigueur
Date de dépôt 2016-12-19
Date de la première publication 2019-01-10
Date d'octroi 2021-03-02
Propriétaire Fujifilm Diosynth Biotechnologies UK Limited (Royaume‑Uni)
Inventeur(s)
  • Heise, Charles
  • Nagy, Tibor

Abrégé

A method of concentration of a liquid comprising a biomolecule is provided. The method comprises passing the liquid through a tangential flow filtration device under pressure, wherein the pressure applied is varied between at least a higher pressure and a lower pressure. Preferably, the variation in pressure is delivered by the use of a variable flow-controller, such as a valve.

Classes IPC  ?

  • C07K 1/34 - ExtractionSéparationPurification par filtration, ultrafiltration ou osmose inverse

42.

Method for processing solutions of biomolecules

      
Numéro d'application 16068465
Numéro de brevet 10682610
Statut Délivré - en vigueur
Date de dépôt 2016-12-19
Date de la première publication 2019-01-10
Date d'octroi 2020-06-16
Propriétaire Fujifilm Diosynth Biotechnologies UK Limited (Royaume‑Uni)
Inventeur(s)
  • Heise, Charles
  • Nagy, Tibor

Abrégé

Apparatus for in-line liquid exchanging a biomolecule-containing liquid is provided. The apparatus comprises a means (3) for mixing at least two liquids comprising a multiple inlet flow-controller (2), the means for mixing also comprising an outlet in fluid connection with a tangential flow filtration device (1) configured in single-pass mode.

Classes IPC  ?

  • B01D 61/18 - Appareils à cet effet
  • B01D 61/20 - AccessoiresOpérations auxiliaires
  • C07K 1/14 - ExtractionSéparationPurification
  • C12N 15/10 - Procédés pour l'isolement, la préparation ou la purification d'ADN ou d'ARN
  • B01D 61/14 - UltrafiltrationMicrofiltration
  • B01D 61/16 - Prétraitement du courant d'alimentation
  • B01D 61/22 - Commande ou régulation

43.

SATURN

      
Numéro d'application 1435634
Statut Enregistrée
Date de dépôt 2018-07-12
Date d'enregistrement 2018-07-12
Propriétaire FUJIFILM Diosynth Biotechnologies UK Limited (Royaume‑Uni)
Classes de Nice  ?
  • 01 - Produits chimiques destinés à l'industrie, aux sciences ainsi qu'à l'agriculture
  • 40 - Traitement de matériaux; recyclage, purification de l'air et traitement de l'eau
  • 42 - Services scientifiques, technologiques et industriels, recherche et conception

Produits et services

Cell cultures used in industry and science; mammalian cell cultures and vectors, being independent replicating pieces of DNA that can transfer DNA sequences, each for manufacture and development in the biotechnology industries. Processing and manufacturing of vectors, cell cultures and recombinant proteins for use in biotechnology industries to the order and specification of others; manufacture, processing and production of recombinant proteins for use in the biotechnology industries to the order and specification of others. Scientific, industrial and technical research, development and analysis services relating to the use of mammalian cell cultures and vectors in the field of biotechnology; process development, namely, development of processes for the use of mammalian cell cultures and vectors in the manufacture of biotechnology products; project studies relating to the use of mammalian cell cultures and vectors in the field of biotechnology.

44.

EXPRESSION SYSTEM

      
Numéro d'application GB2018050649
Numéro de publication 2018/172739
Statut Délivré - en vigueur
Date de dépôt 2018-03-14
Date de publication 2018-09-27
Propriétaire FUJIFILM DIOSYNTH BIOTECHNOLOGIES UK LIMITED (Royaume‑Uni)
Inventeur(s) Lennon, Christopher

Abrégé

A protein expression system for use in a prokaryotic host is provided, the expression system comprising: a) an expression cassette comprising a nucleic acid sequence encoding a protein of interest operably linked to a T7 RNA polymerase-dependent promoter; and b) an expression cassette comprising a nucleic acid sequence encoding T7 RNA polymerase operably linked to a host polymerase-dependent λ phage promoter and a single perfect palindrome operator sequence; wherein the expression cassette for T7 RNA polymerase is located on the chromosome of a host cell.

Classes IPC  ?

  • C12N 15/67 - Méthodes générales pour favoriser l'expression
  • C12N 15/70 - Vecteurs ou systèmes d'expression spécialement adaptés à E. coli
  • C12N 15/73 - Systèmes d'expression utilisant des séquences régulatrices du phage lambda

45.

Expression process

      
Numéro d'application 15838868
Numéro de brevet 11306323
Statut Délivré - en vigueur
Date de dépôt 2017-12-12
Date de la première publication 2018-05-10
Date d'octroi 2022-04-19
Propriétaire Fujifilm Diosynth Biotechnologies UK Limited (Royaume‑Uni)
Inventeur(s)
  • Saunders, Fay Louise
  • Dodds, Anna Louise
  • Bayard, Adeline Marie Geraldine
  • Kara, Bhupendra Vallabh

Abrégé

A process for the production of a target polypeptide is provided. The process comprises expression of an expression vector for expressing a target polypeptide in a host cell, preferably a mammalian cell, the expression vector comprising an expression cassette comprising a polynucleotide encoding a recombinant polypeptide operably linked to a fibronectin secretion leader sequence; and recovering the target polypeptide.

Classes IPC  ?

  • C12N 15/85 - Vecteurs ou systèmes d'expression spécialement adaptés aux hôtes eucaryotes pour cellules animales
  • C07K 16/06 - Immunoglobulines, p. ex. anticorps monoclonaux ou polyclonaux provenant de sérum
  • C07K 16/30 - Immunoglobulines, p. ex. anticorps monoclonaux ou polyclonaux contre du matériel provenant d'animaux ou d'humains contre des récepteurs, des antigènes de surface cellulaire ou des déterminants de surface cellulaire provenant de cellules de tumeurs

46.

Expression system

      
Numéro d'application 15588851
Numéro de brevet 11098335
Statut Délivré - en vigueur
Date de dépôt 2017-05-08
Date de la première publication 2017-08-24
Date d'octroi 2021-08-24
Propriétaire Fujifilm Diosynth Biotechnologies UK Limited (Royaume‑Uni)
Inventeur(s)
  • Kara, Bhupendra Vallabh
  • Lennon, Christopher David John
  • Hodgson, Ian John

Abrégé

A perfect palindrome operator sequence-based protein expression system is provided. The expression system comprises a promoter; and a perfect palindrome operator sequence, wherein the promoter is not T7. The expression system is preferably employed for the production of recombinant proteins by fermentation.

Classes IPC  ?

  • C12P 21/00 - Préparation de peptides ou de protéines
  • C12N 15/70 - Vecteurs ou systèmes d'expression spécialement adaptés à E. coli
  • C12N 15/72 - Systèmes d'expression utilisant des séquences régulatrices dérivées de l'opéron lac
  • C12N 15/73 - Systèmes d'expression utilisant des séquences régulatrices du phage lambda
  • C12R 1/19 - Escherichia coli
  • C12N 15/78 - Vecteurs ou systèmes d'expression spécialement adaptés aux hôtes procaryotes autres que E. coli, p. ex. Lactobacillus, Micromonospora pour Pseudomonas
  • C12N 15/81 - Vecteurs ou systèmes d'expression spécialement adaptés aux hôtes eucaryotes pour champignons pour levures
  • C12N 15/85 - Vecteurs ou systèmes d'expression spécialement adaptés aux hôtes eucaryotes pour cellules animales

47.

TANGENTIAL FLOW FILTRATION PROCESS FOR CONCENTRATING BIOMOLECULE SOLUTIONS

      
Numéro de document 03010431
Statut En instance
Date de dépôt 2016-12-19
Date de disponibilité au public 2017-07-13
Propriétaire FUJIFILM DIOSYNTH BIOTECHNOLOGIES UK LIMITED (Royaume‑Uni)
Inventeur(s)
  • Heise, Charles
  • Nagy, Tibor

Abrégé

A method of concentration of a liquid comprising a biomolecule is provided. The method comprises passing the liquid through a tangential flow filtration device under pressure, wherein the pressure applied is varied between at least a higher pressure and a lower pressure. Preferably, the variation in pressure is delivered by the use of a variable flow- controller, such as a valve.

Classes IPC  ?

  • C07K 1/34 - ExtractionSéparationPurification par filtration, ultrafiltration ou osmose inverse

48.

METHOD FOR PROCESSING SOLUTIONS OF BIOMOLECULES

      
Numéro de document 03010545
Statut Délivré - en vigueur
Date de dépôt 2016-12-19
Date de disponibilité au public 2017-07-13
Date d'octroi 2023-10-03
Propriétaire FUJIFILM DIOSYNTH BIOTECHNOLOGIES UK LIMITED (Royaume‑Uni)
Inventeur(s)
  • Heise, Charles
  • Nagy, Tibor

Abrégé

Apparatus for in-line liquid exchanging a biomolecule-containing liquid is provided. The apparatus comprises a means (3) for mixing at least two liquids comprising a multiple inlet flow-controller (2), the means for mixing also comprising an outlet in fluid connection with a tangential flow filtration device (1) configured in single-pass mode.

Classes IPC  ?

  • B01D 61/18 - Appareils à cet effet
  • B01D 61/20 - AccessoiresOpérations auxiliaires
  • C07K 1/34 - ExtractionSéparationPurification par filtration, ultrafiltration ou osmose inverse
  • C12N 15/10 - Procédés pour l'isolement, la préparation ou la purification d'ADN ou d'ARN

49.

TANGENTIAL FLOW FILTRATION PROCESS FOR CONCENTRATING BIOMOLECULE SOLUTIONS

      
Numéro d'application GB2016053980
Numéro de publication 2017/118835
Statut Délivré - en vigueur
Date de dépôt 2016-12-19
Date de publication 2017-07-13
Propriétaire FUJIFILM DIOSYNTH BIOTECHNOLOGIES UK LIMITED (Royaume‑Uni)
Inventeur(s)
  • Heise, Charles
  • Nagy, Tibor

Abrégé

A method of concentration of a liquid comprising a biomolecule is provided. The method comprises passing the liquid through a tangential flow filtration device under pressure, wherein the pressure applied is varied between at least a higher pressure and a lower pressure. Preferably, the variation in pressure is delivered by the use of a variable flow- controller, such as a valve.

Classes IPC  ?

  • C07K 1/34 - ExtractionSéparationPurification par filtration, ultrafiltration ou osmose inverse

50.

METHOD FOR PROCESSING SOLUTIONS OF BIOMOLECULES

      
Numéro d'application GB2016053981
Numéro de publication 2017/118836
Statut Délivré - en vigueur
Date de dépôt 2016-12-19
Date de publication 2017-07-13
Propriétaire FUJIFILM DIOSYNTH BIOTECHNOLOGIES UK LIMITED (Royaume‑Uni)
Inventeur(s)
  • Heise, Charles
  • Nagy, Tibor

Abrégé

Apparatus for in-line liquid exchanging a biomolecule-containing liquid is provided. The apparatus comprises a means (3) for mixing at least two liquids comprising a multiple inlet flow-controller (2), the means for mixing also comprising an outlet in fluid connection with a tangential flow filtration device (1) configured in single-pass mode.

Classes IPC  ?

  • B01D 61/18 - Appareils à cet effet
  • B01D 61/20 - AccessoiresOpérations auxiliaires
  • C07K 1/34 - ExtractionSéparationPurification par filtration, ultrafiltration ou osmose inverse

51.

Expression process

      
Numéro d'application 14787669
Numéro de brevet 09873891
Statut Délivré - en vigueur
Date de dépôt 2014-04-29
Date de la première publication 2016-03-17
Date d'octroi 2018-01-23
Propriétaire Fujifilm Diosynth Biotechnologies UK Limited (Royaume‑Uni)
Inventeur(s)
  • Saunders, Fay Louise
  • Dodds, Anna Louise
  • Bayard, Adeline Marie Geraldine
  • Kara, Bhupendra Vallabh

Abrégé

A process for the production of a target polypeptide is provided. The process comprises expression of an expression vector for expressing a target polypeptide in a host cell, preferably a mammalian cell, the expression vector comprising an expression cassette comprising a polynucleotide encoding a recombinant polypeptide operably linked to a fibronectin secretion leader sequence; and recovering the target polypeptide.

Classes IPC  ?

  • C12N 15/85 - Vecteurs ou systèmes d'expression spécialement adaptés aux hôtes eucaryotes pour cellules animales
  • C07K 16/06 - Immunoglobulines, p. ex. anticorps monoclonaux ou polyclonaux provenant de sérum
  • C07K 16/30 - Immunoglobulines, p. ex. anticorps monoclonaux ou polyclonaux contre du matériel provenant d'animaux ou d'humains contre des récepteurs, des antigènes de surface cellulaire ou des déterminants de surface cellulaire provenant de cellules de tumeurs

52.

Expression vector

      
Numéro d'application 14880671
Numéro de brevet 09845475
Statut Délivré - en vigueur
Date de dépôt 2015-10-12
Date de la première publication 2016-01-28
Date d'octroi 2017-12-19
Propriétaire Fujifilm Diosynth Biotechnologies UK Limited (Royaume‑Uni)
Inventeur(s)
  • Kara, Bhupendra Vallabh
  • Lennon, Christopher David John

Abrégé

An expression vector for expressing a target polypeptide in a prokaryotic cell is provided. The vector comprises a promoter operably linked to a polynucleotide encoding the target polypeptide operably linked to a eukaryotic secretion leader sequence, the eukaryotic secretion leader sequence encoding a signal peptide sequence selected from the group consisting of: a) MLKRSSWLATLGLLTVASVSTIVYA; b) MKKATFITCLLAVLLVSNPIWNA; c) MKVSAAALAVILIATALCAPASA; d) MKVSTAFLCLLLTVSAFSAQVLA; and e) MKCLLLALGLALACAAQA. Processes for expressing polypeptides and prokaryotic microorganisms comprising such vectors are also provided.

Classes IPC  ?

  • C12N 15/70 - Vecteurs ou systèmes d'expression spécialement adaptés à E. coli
  • C12N 15/62 - Séquences d'ADN codant pour des protéines de fusion

53.

APOLLO

      
Numéro d'application 1251012
Statut Enregistrée
Date de dépôt 2014-10-27
Date d'enregistrement 2014-10-27
Propriétaire FUJIFILM Diosynth Biotechnologies UK Limited (Royaume‑Uni)
Classes de Nice  ?
  • 01 - Produits chimiques destinés à l'industrie, aux sciences ainsi qu'à l'agriculture
  • 40 - Traitement de matériaux; recyclage, purification de l'air et traitement de l'eau
  • 42 - Services scientifiques, technologiques et industriels, recherche et conception

Produits et services

Cell cultures used in industry and science; mammalian cell cultures and vectors, being independent replicating pieces of DNA that can transfer DNA sequences, each for manufacture and development in the biotechnology industries. Processing and manufacturing of vectors, cell cultures and recombinant proteins for use in biotechnology industries to the order and specification of others; manufacture, processing and production of recombinant proteins for use in the biotechnology industries to the order and specification of others. Scientific, industrial and technical research, development and analysis services relating to the use of mammalian cell cultures and vectors in the field of biotechnology; process development, namely, development of processes for the use of mammalian cell cultures and vectors in the manufacture of biotechnology products; project studies relating to the use of mammalian cell cultures and vectors in the field of biotechnology.

54.

USE OF METE GENE AS AUXOTROPHIC MARKER IN GENETIC CONSTRUCTS

      
Numéro d'application GB2014000444
Numéro de publication 2015/071623
Statut Délivré - en vigueur
Date de dépôt 2014-11-04
Date de publication 2015-05-21
Propriétaire FUJIFILM DIOSYNTH BIOTECHNOLOGIES UK LIMITED (Royaume‑Uni)
Inventeur(s) Pointon, Jonathan, Anthony

Abrégé

A process for the production of a target polypeptide is provided. The process comprises expressing an expression cassette for the target recombinant polypeptide comprised in a vector in a non-mammalian host, wherein the host is auxotrophic for methionine and lacks the ability to express functional chromosomal Vitamin B12 independent homocysteine methyltransferase. The vector comprises an expression cassette for functional Vitamin B12 independent homocysteine methyltransferase and the host is cultured in a growth medium lacking methionine.

Classes IPC  ?

  • C12N 15/65 - Introduction de matériel génétique étranger utilisant des vecteursVecteurs Utilisation d'hôtes pour ceux-ciRégulation de l'expression utilisant des marqueurs

55.

DNA CONSTRUCT

      
Numéro d'application GB2014000319
Numéro de publication 2015/033086
Statut Délivré - en vigueur
Date de dépôt 2014-08-18
Date de publication 2015-03-12
Propriétaire FUJIFILM DIOSYNTH BIOTECHNOLOGIES UK LIMITED (Royaume‑Uni)
Inventeur(s) Saunders, Fay Louise

Abrégé

A DNA construct comprising a hamster beta-actin promoter operably linked to a cytomegalovirus enhancer is provided. Preferably the promoter is Chinese hamster beta- actin promoter, and the enhancer is the hCMV Major Intermediate Early enhancer. The DNA constructs can be employed for the production of polypeptides of interest, especially antibodies and antibody fragments.

Classes IPC  ?

  • C12N 15/85 - Vecteurs ou systèmes d'expression spécialement adaptés aux hôtes eucaryotes pour cellules animales

56.

EXPRESSION PROCESS

      
Numéro d'application GB2014000252
Numéro de publication 2015/001285
Statut Délivré - en vigueur
Date de dépôt 2014-06-25
Date de publication 2015-01-08
Propriétaire FUJIFILM DIOSYNTH BIOTECHNOLOGIES UK LIMITED (Royaume‑Uni)
Inventeur(s) Lennon, Christopher David John

Abrégé

A process for production of a target recombinant polypeptide in a prokaryotic cell is provided. The process comprises expressing a vector comprising a first expression cassette comprising a polynucleotide encoding the target polypeptide operably linked to an inducible promoter and comprising a ribosome binding site; and a second expression cassette comprising a polynucleotide encoding an sRNA which targets the ribosome binding region of mRNA which corresponds to the ribosome binding site of the first expression cassette, operably linked to a promoter and wherein the sRNA comprises a sequence of bases complementary to at least a part of the ribosome binding region of the mRNA, which sequence comprises at least 8 consecutive bases in which no more than 15% of the bases exhibit non-Watson-Crick nucleotide base pairing to the ribosome binding region of the mRNA.

Classes IPC  ?

  • C12N 15/63 - Introduction de matériel génétique étranger utilisant des vecteursVecteurs Utilisation d'hôtes pour ceux-ciRégulation de l'expression

57.

Expression process

      
Numéro d'application 13883187
Numéro de brevet 10465220
Statut Délivré - en vigueur
Date de dépôt 2011-11-02
Date de la première publication 2014-12-18
Date d'octroi 2019-11-05
Propriétaire Fujifilm Diosynth Biotechnologies UK Limited (Royaume‑Uni)
Inventeur(s)
  • Kara, Bhupendra Vallabh
  • Lennon, Christopher David John

Abrégé

A process for the production of a target recombinant polypeptide is provided. The process comprises expressing an expression cassette encoding the target polypeptide and co-expressing an expression cassette encoding a mitochondrial foldase. Preferred mitochondrial foldases include Mia 40 and Erv1, and homologs thereof.

Classes IPC  ?

  • C12P 21/00 - Préparation de peptides ou de protéines
  • C12N 9/02 - Oxydoréductases (1.), p. ex. luciférase
  • C12N 9/90 - Isomérases (5.)
  • C12P 21/02 - Préparation de peptides ou de protéines comportant une séquence connue de plusieurs amino-acides, p. ex. glutathion
  • C12N 15/70 - Vecteurs ou systèmes d'expression spécialement adaptés à E. coli

58.

EXPRESSION PROCESS

      
Numéro de document 02910877
Statut Délivré - en vigueur
Date de dépôt 2014-04-29
Date de disponibilité au public 2014-11-06
Date d'octroi 2021-08-03
Propriétaire FUJIFILM DIOSYNTH BIOTECHNOLOGIES UK LIMITED (Royaume‑Uni)
Inventeur(s)
  • Saunders, Fay Louise
  • Dodds, Anna Louise
  • Bayard, Adeline Marie Geraldine
  • Kara, Bhupendra Vallabh

Abrégé

A process for the production of a target polypeptide is provided. The process comprises expression of an expression vector for expressing a target polypeptide in a host cell, preferably a mammalian cell, the expression vector comprising an expression cassette comprising a polynucleotide encoding a recombinant polypeptide operably linked to a fibronectin secretion leader sequence; and recovering the target polypeptide.

Classes IPC  ?

  • C12N 15/85 - Vecteurs ou systèmes d'expression spécialement adaptés aux hôtes eucaryotes pour cellules animales
  • C07K 16/06 - Immunoglobulines, p. ex. anticorps monoclonaux ou polyclonaux provenant de sérum
  • C07K 16/30 - Immunoglobulines, p. ex. anticorps monoclonaux ou polyclonaux contre du matériel provenant d'animaux ou d'humains contre des récepteurs, des antigènes de surface cellulaire ou des déterminants de surface cellulaire provenant de cellules de tumeurs

59.

EXPRESSION PROCESS

      
Numéro d'application GB2014000165
Numéro de publication 2014/177826
Statut Délivré - en vigueur
Date de dépôt 2014-04-29
Date de publication 2014-11-06
Propriétaire FUJIFILM DIOSYNTH BIOTECHNOLOGIES UK LIMITED (Royaume‑Uni)
Inventeur(s)
  • Saunders, Fay Louise
  • Dodds, Anna Louise
  • Bayard, Adeline Marie Geraldine
  • Kara, Bhupendra Vallabh

Abrégé

A process for the production of a target polypeptide is provided. The process comprises expression of an expression vector for expressing a target polypeptide in a host cell, preferably a mammalian cell, the expression vector comprising an expression cassette comprising a polynucleotide encoding a recombinant polypeptide operably linked to a fibronectin secretion leader sequence; and recovering the target polypeptide.

Classes IPC  ?

  • C12N 15/85 - Vecteurs ou systèmes d'expression spécialement adaptés aux hôtes eucaryotes pour cellules animales
  • C07K 16/06 - Immunoglobulines, p. ex. anticorps monoclonaux ou polyclonaux provenant de sérum
  • C07K 16/30 - Immunoglobulines, p. ex. anticorps monoclonaux ou polyclonaux contre du matériel provenant d'animaux ou d'humains contre des récepteurs, des antigènes de surface cellulaire ou des déterminants de surface cellulaire provenant de cellules de tumeurs

60.

APOLLO

      
Numéro de série 79166815
Statut Enregistrée
Date de dépôt 2014-10-27
Date d'enregistrement 2015-10-13
Propriétaire FUJIFILM Diosynth Biotechnologies UK Limited (Royaume‑Uni)
Classes de Nice  ?
  • 40 - Traitement de matériaux; recyclage, purification de l'air et traitement de l'eau
  • 01 - Produits chimiques destinés à l'industrie, aux sciences ainsi qu'à l'agriculture
  • 42 - Services scientifiques, technologiques et industriels, recherche et conception

Produits et services

Processing and manufacturing of vectors, cell cultures and recombinant proteins for use in biotechnology industries to the order and specification of others; manufacture, processing and production of recombinant proteins for use in the biotechnology industries to the order and specification of others [ Cell cultures used in industry and science; mammalian cell cultures and vectors, being independent replicating pieces of DNA that can transfer DNA sequences, each for manufacture and development in the biotechnology industries ] Scientific, industrial and technical research, development and analysis services relating to the use of mammalian cell cultures and vectors in the field of biotechnology; process development, namely, development of processes for the use of mammalian cell cultures and vectors in the manufacture of biotechnology products; project studies relating to the use of mammalian cell cultures and vectors in the field of biotechnology

61.

Methylotrophic yeast transformed with gal promoters

      
Numéro d'application 14237021
Numéro de brevet 09051576
Statut Délivré - en vigueur
Date de dépôt 2012-07-26
Date de la première publication 2014-06-12
Date d'octroi 2015-06-09
Propriétaire Fujifilm Diosynth Biotechnologies UK Limited (Royaume‑Uni)
Inventeur(s) Kara, Bhupendra Vallabh

Abrégé

S. cerevisiae GAL1 or GAL10 promoter. Vectors and methods for producing recombinant polypeptides are also provided.

Classes IPC  ?

  • C12P 21/02 - Préparation de peptides ou de protéines comportant une séquence connue de plusieurs amino-acides, p. ex. glutathion
  • C12N 15/81 - Vecteurs ou systèmes d'expression spécialement adaptés aux hôtes eucaryotes pour champignons pour levures
  • C12P 21/00 - Préparation de peptides ou de protéines

62.

Expression system

      
Numéro d'application 13966600
Numéro de brevet 09677103
Statut Délivré - en vigueur
Date de dépôt 2013-08-14
Date de la première publication 2014-03-06
Date d'octroi 2017-06-13
Propriétaire Fujifilm Diosynth Biotechnologies UK Limited (Royaume‑Uni)
Inventeur(s)
  • Kara, Bhupendra Vallabh
  • Lennon, Christopher David John
  • Hodgson, Ian John

Abrégé

A perfect palindrome operator sequence-based protein expression system is provided. The expression system comprises a promoter; and a perfect palindrome operator sequence, wherein the promoter is not T7. The expression system is preferably employed for the production of recombinant proteins by fermentation.

Classes IPC  ?

  • C12P 21/00 - Préparation de peptides ou de protéines
  • C12N 15/70 - Vecteurs ou systèmes d'expression spécialement adaptés à E. coli
  • C12N 15/72 - Systèmes d'expression utilisant des séquences régulatrices dérivées de l'opéron lac
  • C12N 15/78 - Vecteurs ou systèmes d'expression spécialement adaptés aux hôtes procaryotes autres que E. coli, p. ex. Lactobacillus, Micromonospora pour Pseudomonas
  • C12N 15/81 - Vecteurs ou systèmes d'expression spécialement adaptés aux hôtes eucaryotes pour champignons pour levures
  • C12N 15/85 - Vecteurs ou systèmes d'expression spécialement adaptés aux hôtes eucaryotes pour cellules animales
  • C12N 15/73 - Systèmes d'expression utilisant des séquences régulatrices du phage lambda
  • C12R 1/19 - Escherichia coli

63.

PROCESS FOR EXPRESSION OF CRM197

      
Numéro d'application GB2013000238
Numéro de publication 2013/178974
Statut Délivré - en vigueur
Date de dépôt 2013-05-23
Date de publication 2013-12-05
Propriétaire FUJIFILM DIOSYNTH BIOTECHNOLOGIES UK LIMITED (Royaume‑Uni)
Inventeur(s)
  • Kara, Bhupendra Vallabh
  • Lennon, Christopher David John

Abrégé

In one aspect, a process for the intracellular expression of CRM197 in an E coli host is provided. The process comprises expressing a vector comprising a gene encoding CRM 197 operably linked to a promoter and at least one perfect palindrome operator sequence. In a related aspect, a process for the periplasmic expression of CRM197 in an E coli host is provided, comprising expressing a vector comprising a gene encoding CRM197 and a secretion leader sequence operably linked to a weak promoter system comprising at least one perfect palindrome operator sequence.

Classes IPC  ?

  • A61K 47/48 - Préparations médicinales caractérisées par les ingrédients non actifs utilisés, p.ex. supports, additifs inertes l'ingrédient non actif étant chimiquement lié à l'ingrédient actif, p.ex. conjugués polymère-médicament
  • C07K 14/34 - Peptides ayant plus de 20 amino-acidesGastrinesSomatostatinesMélanotropinesLeurs dérivés provenant de bactéries provenant de Corynebacterium (G)
  • C12N 15/70 - Vecteurs ou systèmes d'expression spécialement adaptés à E. coli
  • C12N 15/72 - Systèmes d'expression utilisant des séquences régulatrices dérivées de l'opéron lac
  • C12N 15/73 - Systèmes d'expression utilisant des séquences régulatrices du phage lambda

64.

Expression process

      
Numéro d'application 13996364
Numéro de brevet 09677104
Statut Délivré - en vigueur
Date de dépôt 2011-12-10
Date de la première publication 2013-10-17
Date d'octroi 2017-06-13
Propriétaire Fujifilm Diosynth Biotechnologies UK Limited (Royaume‑Uni)
Inventeur(s)
  • Hodgson, Ian John
  • Nagy, Tibor

Abrégé

A process for the production of a target recombinant polypeptide is provided. The process comprises expressing a vector comprising a promoter operatively linked to an expression cassette for the target recombinant polypeptide; and a perfect palindrome operator sequence in a culture medium, wherein the culture medium is substantially free from antibiotic.

Classes IPC  ?

  • C12N 15/67 - Méthodes générales pour favoriser l'expression
  • C12P 21/00 - Préparation de peptides ou de protéines
  • C12N 15/70 - Vecteurs ou systèmes d'expression spécialement adaptés à E. coli

65.

PURIFICATION PROCESS FOR POLYPEPTIDES

      
Numéro d'application GB2012000617
Numéro de publication 2013/021148
Statut Délivré - en vigueur
Date de dépôt 2012-07-27
Date de publication 2013-02-14
Propriétaire FUJIFILM DIOSYNTH BIOTECHNOLOGIES UK LIMITED (Royaume‑Uni)
Inventeur(s) Conradie, Alex Van Eck

Abrégé

A process for the purification of a high-potency polypeptide is provided. The process comprises contacting a crude mixture comprising a high-potency polypeptide and one or more impurities with a purification medium using a supply line; and contacting one or more processing solutions with the purification medium using a supply line, whereby the concentration of one or more impurities relative to the high-potency polypeptide is reduced, characterised in that the supply line for the high potency polypeptide is a disposable supply line separate from the supply line for the processing solutions.

Classes IPC  ?

  • C07K 1/14 - ExtractionSéparationPurification

66.

METHYLOTROPHIC YEAST TRANSFORMED WITH GAL PROMOTERS

      
Numéro d'application GB2012000616
Numéro de publication 2013/017813
Statut Délivré - en vigueur
Date de dépôt 2012-07-26
Date de publication 2013-02-07
Propriétaire FUJIFILM DIOSYNTH BIOTECHNOLOGIES UK LIMITED (Royaume‑Uni)
Inventeur(s) Kara, Bhupendra Vallabh

Abrégé

A recombinant yeast of the genus Komagataella which has been transformed with a galactose promoter is provided. The yeast is preferably Komagataella phaffii, and the promoter is preferably a S. cerevisiae GAL1 or GAL10 promoter. Vectors and methods for producing recombinant polypeptides are also provided.

Classes IPC  ?

  • C12R 1/78 - Hansenula
  • C12R 1/84 - Pichia
  • C12N 15/81 - Vecteurs ou systèmes d'expression spécialement adaptés aux hôtes eucaryotes pour champignons pour levures

67.

CELL LYSIS PROCESS

      
Numéro d'application GB2012000164
Numéro de publication 2012/114063
Statut Délivré - en vigueur
Date de dépôt 2012-02-17
Date de publication 2012-08-30
Propriétaire FUJIFILM DIOSYNTH BIOTECHNOLOGIES UK LIMITED (Royaume‑Uni)
Inventeur(s)
  • Liddell John Macdonald
  • Razzaq Azam

Abrégé

A process for cell lysis is provided. The process comprises passing a mixture comprising a suspension of cells and a lysis reagent through a flow-through reactor, wherein the mixture passes through the reactor with pulsed or superimposed oscillating flow. The process is preferably employed for the preparation of biological products, such as pDNA or inclusion bodies.

Classes IPC  ?

  • C12N 1/06 - Lyse des micro-organismes
  • C12N 1/00 - Micro-organismes, p. ex. protozoairesCompositions les contenantProcédés de culture ou de conservation de micro-organismes, ou de compositions les contenantProcédés de préparation ou d'isolement d'une composition contenant un micro-organismeLeurs milieux de culture

68.

EXPRESSION PROCESS

      
Numéro d'application GB2011001725
Numéro de publication 2012/085496
Statut Délivré - en vigueur
Date de dépôt 2011-12-10
Date de publication 2012-06-28
Propriétaire FUJIFILM DIOSYNTH BIOTECHNOLOGIES UK LIMITED (Royaume‑Uni)
Inventeur(s)
  • Hodgson, Ian, John
  • Nagy, Tibor

Abrégé

A process for the production of a target recombinant polypeptide is provided. The process comprises expressing a vector comprising a promoter operatively linked to an expression cassette for the target recombinant polypeptide; and a perfect palindrome operator sequence in a culture medium, wherein the culture medium is substantially free from antibiotic.

Classes IPC  ?

  • C12R 1/19 - Escherichia coli
  • C12N 15/70 - Vecteurs ou systèmes d'expression spécialement adaptés à E. coli
  • C12N 15/72 - Systèmes d'expression utilisant des séquences régulatrices dérivées de l'opéron lac
  • C12N 15/67 - Méthodes générales pour favoriser l'expression

69.

Plasmid DNA extraction process

      
Numéro d'application 13380699
Numéro de brevet 08889852
Statut Délivré - en vigueur
Date de dépôt 2010-07-22
Date de la première publication 2012-05-17
Date d'octroi 2014-11-18
Propriétaire Fujifilm Diosynth Biotechnologies UK Limited (Royaume‑Uni)
Inventeur(s) Liddell, John Macdonald

Abrégé

A process for the extraction of pDNA from cells is provided. In one aspect, the process comprises heating a liquid comprising the cells to an average temperature of from 95° C. to about 120° C. for a time of less than 10 seconds. In certain preferred aspects, the pDNA is extracted by the use of flow-through apparatus.

Classes IPC  ?

  • C07H 21/00 - Composés contenant au moins deux unités mononucléotide comportant chacune des groupes phosphate ou polyphosphate distincts liés aux radicaux saccharide des groupes nucléoside, p. ex. acides nucléiques
  • C12N 15/10 - Procédés pour l'isolement, la préparation ou la purification d'ADN ou d'ARN

70.

EXPRESSION PROCESS

      
Numéro d'application GB2011001548
Numéro de publication 2012/059715
Statut Délivré - en vigueur
Date de dépôt 2011-11-02
Date de publication 2012-05-10
Propriétaire FUJIFILM DIOSYNTH BIOTECHNOLOGIES UK LIMITED (Royaume‑Uni)
Inventeur(s)
  • Kara, Bhupendra Vallabh
  • Lennon, Christopher David John

Abrégé

A process for the production of a target recombinant polypeptide is provided. The process comprises expressing an expression cassette encoding the target polypeptide and co- expressing an expression cassette encoding a mitochondrial foldase. Preferred mitochondrial foldases include Mia 40 and Erv1, and homologs thereof.

Classes IPC  ?

  • C12P 21/02 - Préparation de peptides ou de protéines comportant une séquence connue de plusieurs amino-acides, p. ex. glutathion
  • C12N 9/02 - Oxydoréductases (1.), p. ex. luciférase

71.

Purification process for fragment antibodies

      
Numéro d'application 13122676
Numéro de brevet 09447171
Statut Délivré - en vigueur
Date de dépôt 2009-10-02
Date de la première publication 2011-08-04
Date d'octroi 2016-09-20
Propriétaire Fujifilm Diosynth Biotechnologies UK Limited (Royaume‑Uni)
Inventeur(s) Liddell, John Macdonald

Abrégé

A process for purification of a fragment antibody from a culture medium also comprising at least one impurity is provided. The purification is carried out after the pH of the culture medium has been reduced to a pH at which the fragment antibody is soluble, but one or more of the impurities are insoluble. A process for the preparation of a fragment antibody employing such a purification process is also provided.

Classes IPC  ?

  • C07K 1/14 - ExtractionSéparationPurification
  • C07K 1/36 - ExtractionSéparationPurification par une combinaison de plusieurs procédés de types différents
  • C07K 1/30 - ExtractionSéparationPurification par précipitation
  • C07K 16/06 - Immunoglobulines, p. ex. anticorps monoclonaux ou polyclonaux provenant de sérum
  • C07K 16/24 - Immunoglobulines, p. ex. anticorps monoclonaux ou polyclonaux contre du matériel provenant d'animaux ou d'humains contre des cytokines, des lymphokines ou des interférons
  • C07K 19/00 - Peptides hybrides
  • C07K 16/00 - Immunoglobulines, p. ex. anticorps monoclonaux ou polyclonaux
  • C07K 16/40 - Immunoglobulines, p. ex. anticorps monoclonaux ou polyclonaux contre des enzymes

72.

Expression vector for expression of eukaryotic secretion leader sequence fused with a target polypeptide and methods of use thereof

      
Numéro d'application 12995924
Numéro de brevet 09157085
Statut Délivré - en vigueur
Date de dépôt 2009-06-01
Date de la première publication 2011-04-14
Date d'octroi 2015-10-13
Propriétaire Fujifilm Diosynth Biotechnologies UK Limited (Royaume‑Uni)
Inventeur(s)
  • Kara, Bhupendra Vallabh
  • Lennon, Christopher David John

Abrégé

An expression vector for expressing a target polypeptide in a prokaryotic cell is provided. The vector comprises a promoter operably linked to a polynucleotide encoding the target polypeptide operably linked to a eukaryotic secretion leader sequence, the eukaryotic secretion leader sequence encoding a signal peptide sequence selected from the group consisting of: a) MLKRSSWLATLGLLTVASVSTIVYA; b) MKKATFITCLLAVLLVSNPIWNA; c) MKVSAAALAVILIATALCAPASA; d) MKVSTAFLCLLLTVSAFSAQVLA; and e) MKCLLLALGLALACAAQA. Processes for expressing polypeptides and prokaryotic microorganisms comprising such vectors are also provided.

Classes IPC  ?

  • C12N 15/62 - Séquences d'ADN codant pour des protéines de fusion
  • C12N 15/70 - Vecteurs ou systèmes d'expression spécialement adaptés à E. coli

73.

STEM CELL CONDITIONED MEDIUM COMPOSITIONS

      
Numéro d'application GB2010001739
Numéro de publication 2011/033260
Statut Délivré - en vigueur
Date de dépôt 2010-09-16
Date de publication 2011-03-24
Propriétaire FUJIFILM DIOSYNTH BIOTECHNOLOGIES UK LIMITED (Royaume‑Uni)
Inventeur(s) Kara, Bhupendra Vallabh

Abrégé

A process for preparing a conditioned cell culture medium is provided. The process comprises a) culturing eukaryotic cells in a growth medium having a composition effective to support cell growth; b) separating the cultured cells from the growth medium; and c) maintaining the cultured cells in a basal medium having a composition suitable to maintain cell viability, but not to support substantial cell growth. The cells are preferably dermal sheath, dermal papilla or dermal fibroblast cells. The compositions are useful as pharmaceutical compositions, especially for wound healing.

Classes IPC  ?

  • C12N 5/071 - Cellules ou tissus de vertébrés, p. ex. cellules humaines ou tissus humains
  • A61K 35/36 - PeauSystème pileuxOnglesGlandes sébacéesCérumenÉpidermeCellules épithélialesKératinocytesCellules de LangerhansCellules ectodermiques
  • A61P 17/02 - Médicaments pour le traitement des troubles dermatologiques pour traiter les blessures, les ulcères, les brûlures, les cicatrices, les cheloïdes, ou similaires

74.

PLASMID DNA EXTRACTION PROCESS

      
Numéro d'application GB2010001388
Numéro de publication 2011/012841
Statut Délivré - en vigueur
Date de dépôt 2010-07-22
Date de publication 2011-02-03
Propriétaire FUJIFILM DIOSYNTH BIOTECHNOLOGIES UK LIMITED (Royaume‑Uni)
Inventeur(s) Liddell, John Macdonald

Abrégé

A process for the extraction of pDNA from cells is provided. In one aspect, the process comprises heating a liquid comprising the cells to an average temperature of from 95°C to about 120°C for a time of less than 10 seconds. In certain preferred aspects, the pDNA is extracted by the use of flow-through apparatus.

Classes IPC  ?

  • C12N 1/06 - Lyse des micro-organismes
  • C12N 15/10 - Procédés pour l'isolement, la préparation ou la purification d'ADN ou d'ARN

75.

EXPRESSION PROCESS

      
Numéro d'application GB2010000547
Numéro de publication 2010/109187
Statut Délivré - en vigueur
Date de dépôt 2010-03-24
Date de publication 2010-09-30
Propriétaire FUJIFILM DIOSYNTH BIOTECHNOLOGIES UK LIMITED (Royaume‑Uni)
Inventeur(s) Kara, Bhupendra Vallabh

Abrégé

An expression system for the production of a target polypeptide is provided. The expression system comprises an expression cassette comprising an inducible promoter operably linked to DNA encoding the target polypeptide and an expression cassette for over-expression of DNA binding transcriptional regulator protein, comprising a promoter operably linked to DNA encoding the DNA binding transcriptional regulator protein. The expression cassettes are under the control of orthogonal promoters.

Classes IPC  ?

  • C12N 15/70 - Vecteurs ou systèmes d'expression spécialement adaptés à E. coli
  • C12N 15/72 - Systèmes d'expression utilisant des séquences régulatrices dérivées de l'opéron lac

76.

Expression system

      
Numéro d'application 12599529
Numéro de brevet 08394937
Statut Délivré - en vigueur
Date de dépôt 2008-05-08
Date de la première publication 2010-06-03
Date d'octroi 2013-03-12
Propriétaire Fujifilm Diosynth Biotechnologies UK Limited (Royaume‑Uni)
Inventeur(s)
  • Kara, Bhupendra Vallabh
  • Hodgson, Ian John

Abrégé

b) an expression cassette for T7 RNA polymerase operably linked to a λpL promoter and at least two perfect palindrome operator sequences.

Classes IPC  ?

  • C07H 21/04 - Composés contenant au moins deux unités mononucléotide comportant chacune des groupes phosphate ou polyphosphate distincts liés aux radicaux saccharide des groupes nucléoside, p. ex. acides nucléiques avec le désoxyribosyle comme radical saccharide
  • C12N 15/70 - Vecteurs ou systèmes d'expression spécialement adaptés à E. coli
  • C12N 1/21 - BactériesLeurs milieux de culture modifiés par l'introduction de matériel génétique étranger

77.

Expression system

      
Numéro d'application 12223527
Numéro de brevet 08530188
Statut Délivré - en vigueur
Date de dépôt 2007-02-01
Date de la première publication 2009-07-02
Date d'octroi 2013-09-10
Propriétaire Fujifilm Diosynth Biotechnologies (UK) Limited (Royaume‑Uni)
Inventeur(s)
  • Kara, Bhupendra Vallabh
  • Lennon, Christopher David John
  • Hodgson, Ian John

Abrégé

A perfect palindrome operator sequence-based protein expression system is provided. The expression system comprises a promoter; and a perfect palindrome operator sequence, wherein the promoter is not T7. The expression system is preferably employed for the production of recombinant proteins by fermentation.

Classes IPC  ?

  • C12N 15/09 - Technologie d'ADN recombinant
  • C12N 1/21 - BactériesLeurs milieux de culture modifiés par l'introduction de matériel génétique étranger
  • C12N 15/00 - Techniques de mutation ou génie génétiqueADN ou ARN concernant le génie génétique, vecteurs, p. ex. plasmides, ou leur isolement, leur préparation ou leur purificationUtilisation d'hôtes pour ceux-ci

78.

PAVEWAY

      
Numéro de série 77504361
Statut Enregistrée
Date de dépôt 2008-06-20
Date d'enregistrement 2009-09-08
Propriétaire FUJIFILM DIOSYNTH BIOTECHNOLOGIES UK LIMITED (Royaume‑Uni)
Classes de Nice  ?
  • 01 - Produits chimiques destinés à l'industrie, aux sciences ainsi qu'à l'agriculture
  • 40 - Traitement de matériaux; recyclage, purification de l'air et traitement de l'eau
  • 42 - Services scientifiques, technologiques et industriels, recherche et conception

Produits et services

(Based on 44(e)) [ Microbially produced chemicals used in industry and science; microbial preparations used in industry and science; proteins, enzymes, and cultures of micro organisms used in industry and science; chemical reagents for non-medical purposes; genes being DNA sequences for manufacture and development in the biotechnology and pharmaceutical industries; plasmids being small independently replicating pieces of DNA and vectors being small independent replicating pieces of DNA that can transfer DNA sequences all for manufacture and development in the biotechnology and pharmaceutical industries ] (Based on Use in Commerce) Processing and manufacturing of chemicals and proteins for use in biotechnology and pharmaceutical industries to the order and specification of others; manufacture, processing and production of scientific and industrial products, namely, chemicals and proteins for use in the biotechnology and pharmaceutical industries to the order and specification of others (Based on Use in Commerce) Scientific, industrial and technical research, development and analysis services in the field of biotechnology and pharmaceuticals; process development, namely, development of chemicals for use in the manufacture of biotechnology products and pharmaceuticals; industrial design services; provision of facilities for scientific, industrial and technical research development in the field of biotechnology and pharmaceuticals; research and development of scientific, industrial and technical products; projects studies in the field of biotechnology and pharmaceuticals; testing of scientific, industrial and technical products in the field of biotechnology and pharmaceuticals

79.

pAVEway

      
Numéro d'application 006761043
Statut Enregistrée
Date de dépôt 2008-03-18
Date d'enregistrement 2009-02-09
Propriétaire FUJIFILM Diosynth Biotechnologies UK Limited (Royaume‑Uni)
Classes de Nice  ?
  • 01 - Produits chimiques destinés à l'industrie, aux sciences ainsi qu'à l'agriculture
  • 40 - Traitement de matériaux; recyclage, purification de l'air et traitement de l'eau
  • 42 - Services scientifiques, technologiques et industriels, recherche et conception

Produits et services

Chemicals used in industry and science; proteins, enzymes; microbial preparations; cultures of micro-organisms; chemical reagents; genes being DNA sequences; plasmids being small independently replicating pieces of DNA and vectors being small independently replicating pieces of DNA that can transfer DNA sequences. Processing and manufacturing of chemicals and proteins, including to the order and specification of others; manufacture, processing and production of scientific and industrial products to the order and specification of others. Scientific, industrial and technical research, development and analysis services; process development; industrial design services; provision of facilities for scientific, industrial and technical research development; research and development of scientific, industrial and technical products; project studies; testing of scientific, industrial and technical products.

80.

EXPRESSION SYSTEM

      
Numéro de document 02959915
Statut Délivré - en vigueur
Date de dépôt 2007-02-01
Date de disponibilité au public 2007-08-09
Date d'octroi 2022-11-15
Propriétaire FUJIFILM DIOSYNTH BIOTECHNOLOGIES UK LIMITED (Royaume‑Uni)
Inventeur(s)
  • Hodgson, Ian John
  • Lennon, Christopher David John
  • Kara, Bhupendra Vallabh

Abrégé

A protein expression system is provided. The expression system comprises a promoter; and a perfect palindrome operator sequence. In an embodiment, the promoter is T7A1, T7A2, T7A3, .lambda.pL, .lambda.pR, lacUV5, trp, trc, phoA and rrnB. In another embodiment, the promoter is an E. coli polymerase-dependent promoter, and the perfect palindrome operator sequence overlaps with the transcriptional start point. In another embodiment, there is proved a vector comprising a yeast promoter, and a perfect palindrome operator sequence. In another embodiment, there is provided a method for the production of a protein which comprises expressing, in a mammalian cell culture, an expression system comprising: a) a mammalian promoter; and b) two or more perfect palindrome operator sequences, at least one operator sequence being located downstream of the promoter, and at least one operator sequence being located upstream of the promoter; and c) an expression cassette for a recombinant protein.

Classes IPC  ?

  • C12N 15/63 - Introduction de matériel génétique étranger utilisant des vecteursVecteurs Utilisation d'hôtes pour ceux-ciRégulation de l'expression
  • C12N 15/113 - Acides nucléiques non codants modulant l'expression des gènes, p. ex. oligonucléotides anti-sens
  • C12N 1/19 - LevuresLeurs milieux de culture modifiés par l'introduction de matériel génétique étranger
  • C12N 1/21 - BactériesLeurs milieux de culture modifiés par l'introduction de matériel génétique étranger
  • C12N 5/10 - Cellules modifiées par l'introduction de matériel génétique étranger, p. ex. cellules transformées par des virus
  • C12N 15/70 - Vecteurs ou systèmes d'expression spécialement adaptés à E. coli
  • C12N 15/81 - Vecteurs ou systèmes d'expression spécialement adaptés aux hôtes eucaryotes pour champignons pour levures
  • C12N 15/85 - Vecteurs ou systèmes d'expression spécialement adaptés aux hôtes eucaryotes pour cellules animales
  • C12P 21/02 - Préparation de peptides ou de protéines comportant une séquence connue de plusieurs amino-acides, p. ex. glutathion

81.

EXPRESSION SYSTEM

      
Numéro de document 02637818
Statut Délivré - en vigueur
Date de dépôt 2007-02-01
Date de disponibilité au public 2007-08-09
Date d'octroi 2017-05-02
Propriétaire FUJIFILM DIOSYNTH BIOTECHNOLOGIES UK LIMITED (Royaume‑Uni)
Inventeur(s)
  • Hodgson, Ian John
  • Lennon, Christopher David John
  • Kara, Bhupendra Vallabh

Abrégé

A perfect palindrome operator sequence-based protein expression system is provided. The expression system comprises a promoter; and a perfect palindrome operator sequence, wherein the promoter is not T7. The expression system is preferably employed for the production of recombinant proteins by fermentation.

Classes IPC  ?

  • C12N 15/70 - Vecteurs ou systèmes d'expression spécialement adaptés à E. coli
  • C12N 15/113 - Acides nucléiques non codants modulant l'expression des gènes, p. ex. oligonucléotides anti-sens
  • C12N 1/21 - BactériesLeurs milieux de culture modifiés par l'introduction de matériel génétique étranger
  • C12N 15/63 - Introduction de matériel génétique étranger utilisant des vecteursVecteurs Utilisation d'hôtes pour ceux-ciRégulation de l'expression
  • C12P 21/02 - Préparation de peptides ou de protéines comportant une séquence connue de plusieurs amino-acides, p. ex. glutathion